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ABSTRACT 
Epidemiological studies suggest that moderate exercise is associated with 
improved resistance to infection; it has also been shown that acute exhaustive exercise is 
associated with increased susceptibility to infection, particularly upper respiratory tract 
infections. Seasonal influenza virus is a contagious upper respiratory tract infection that 
can lead to widespread morbidity and mortality each year, despite the availability of a 
vaccine for influenza. Type I interferons (IFNs) are one of the body’s first lines of 
defense against viral infection. Influenza	  vaccines	  containing	  interferon-­‐α	  (IFNα)	  have	  been	  shown	  to	  increase	  antigen-­‐specific	  antibody	  titer.	  The purpose of the experiments 
carried out in this dissertation were to first determine a possible mechanism for the 
increase in infection resistance seen after moderate exercise as well as the decline in 
resistance to infection post exhaustive exercise, and second to determine the role exercise 
might play in the response to influenza vaccination. The first group of experiments tested 
the effect of different durations of exercise on the production of IFNα by influenza-
stimulated plasmacytoid dendritic cells. Levels of IFNα were shown to be significantly 
increased after 90min of exercise but significantly decreased after 180min of exercise. 
The temporary exercise-induced increase in antiviral function by pDCs may contribute to 
the reduction of infection observed in regular exercisers. There was also a greater 
increase in IFNα production in cells stimulated with norepinephrine or epinephrine 
compared to control. The second set of experiments tested the effects of exercise 
immediately following influenza vaccination on the immune system. Subjects exercising 
for 90min immediately following influenza vaccination showed a significantly greater 
antigen specific antibody response at 2 and 4 weeks post vaccination. Subjects that 
	  	   v	  
reported the greatest levels of stress also had the smallest increases in antibody. In the 
third set of experiments, the duration of exercise post vaccination as well as specific 
mechanisms of action were tested. Mice who exercised for 90min post vaccination 
showed significantly greater antibody responses to vaccination than 0, 45 or 180min of 
exercise at 4 weeks post vaccination. Exercise mice also showed significantly greater 
levels of antigen- experienced CD4 and CD8 T cells compared to the no exercise group. 
The findings from these three separate experiments show that moderate intensity exercise 
induced increases in IFNα and that moderate intensity exercise for 90min might be used 
as a vaccine “adjuvant” if performed immediately post vaccination.  
 
 




 GENERAL INTRODUCTION 
 
 
Organization of Dissertation 
	  
This dissertation contains manuscripts that are being prepared for submission to 
peer reviewed journals. The dissertation consists of five chapters, a general introduction 
including a literature review, three research papers, a general conclusion, which covers 
the overall findings of the dissertation as a whole and finally acknowledgements. The 
references for each of the 3 research papers (chapters II, III and IV) are found at the end 
of their corresponding chapter. The references for chapters I and V are found at the 
conclusion of the dissertation. Each chapter will contain its own figures at the conclusion 
of the chapter and figure numbers will start new with each subsequent chapter. The first 
chapter, General Introduction, includes an introduction to the dissertation, which includes 
current understandings of influenza virus as well as current information on influenza 
vaccines as well as the research objectives of the dissertation. Also within Chapter 1 is a 
review of the literature, which provides a brief background on the immune system, 
influenza viral infection, influenza life cycle, immune responses to influenza virus 
infection, vaccines, and a brief overview of exercise immunology.  Chapters II and III are 
focused almost entirely on human research and influenza viral infection in humans. 
Chapter IV moves to an animal model of infection and continues to look at influenza 
viral infection as well as vaccination. Chapter II focuses on innate immune responses to 
exercise and specifically mechanisms of innate immunity that are affected by exercise 
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and neuroendocrine factors. Chapters III and IV focus more on using longer duration 
moderate exercise as a possible adjuvant to influenza vaccine. Chapter III focuses 
primarily on human vaccination and the antibody response, Chapter IV focuses on these 
same aspects but also adds in some more specific cell mediated immunity in a mouse 
model. This dissertation contains the results and experimental data that was collected by 
the author and his colleagues during his time as a Ph.D. student in Kinesiology and 
Immunobiology graduate programs at Iowa State University, under the supervision of his 
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Introduction to the dissertation 
	   There are positive health benefits from moderate exercise that can be seen in all 
systems of the body and across all age groups42, 131. Numerous studies each year point to 
the long term health benefits of exercise participation, which could be one of the factors 
leading to the large increase in the number of people competing in endurance type 
competitions like road races and triathlons each year1. Studies suggest that this moderate 
intensity exercise can be associated with improved resistance to infection. However, 
other studies have also shown that acute exhaustive exercise can be associated with 
increased susceptibility to infection. The idea that moderate exercise can be beneficial 
and exhaustive exercise can lead to increased illness susceptibility is often best described 
through a model proposed by David Neiman that shows the relationship between exercise 
and the risk of respiratory tract infections (URTI), this was referred to as the J curve 88 
(Fig 1). This specific model will be discussed further in the literature review of exercise 
immunology. The exact mechanisms of this difference in immune response to varying 
durations and intensities of exercise are not completely understood. Determining the 
mechanisms behind these differences may prove important in preventing infections as 
well as providing important recommendations for exercise interventions in both the sick 
and healthy populations.  
 Seasonal influenza virus is a highly contagious upper respiratory tract infection 
that can lead to widespread morbidity and mortality each year 31, 85.  Despite the 
availability of a vaccine for influenza, the infection  still results in thousands of deaths 
each year, with the majority of these deaths occurring in the elderly population. One 
reason for this could be the poor response to vaccination seen in the elderly population69. 
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Conversely, novel strains of influenza have been shown to have a greater effect on the 
younger population76. In lieu of this it is imperative that we find ways to enhance the 
response to the vaccine as well as develop strategies for improving overall immune 
health.  
 One potential solution may be to use exercise as a means of not only enhancing 
immune responses, but also as a way of improving the response to vaccination. The 
purpose of the research involved in this dissertation was to: A) better understand the 
mechanisms by which the duration and intensity of exercise affect the immune system, 
particularly in response to viral challenge, B) determine if exercise can be utilized as a 
potential vaccine adjuvant and C) establish by what mechanisms exercise produces 




1. The Immune System 
Despite the existing knowledge base, the immune system is one of the least 
understood systems of the body. Every day new pathways and molecules are discovered 
and put into the existing models we have. This review will seek to discuss the aspects and 
portions of the immune system that are most applicable to the research at hand. First there 
will be a basic overview of the immune system at large. This overview will be followed 
by a brief discussion on the two major parts of the immune system, the innate and the 
adaptive.  
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The immune system provides defense against invasion of the host by foreign, 
‘non-self’ substances. These substances include pathogenic bacteria, viruses, tumors 
(both non self as well as altered self), fungi and parasites. The goal of the immune system 
is to recognize these invaders and deal with them in a way that eliminates them and 
causes no damage to ‘self’.  The immune system also responds to endogenous “danger 
signals” in an appropriate manner to limit damage.  However, the immune system may 
also be involved in autoimmune diseases or hypersensitivity reactions of the immune 
system that can results in immune pathology. The activation of the immune system can 
be seen as a calculated risk, however in most cases the benefits outweigh the risks. The 
importance of a properly functioning immune system can be seen by the fact that diseases 
affecting the immune system usually result in severe consequences for the host.  
The immune system has two function divisions: the innate or non-specific 
immune system and the adaptive or specific immune system. Non-specific immunity acts 
as first line of defense against infectious agents. Most potential pathogens are controlled 
before they establish an all out infection. If these first defenses are breached the specific 
immune system is activated and produces a specific reaction to each different infectious 
pathogen and that pathogen is typically eliminated. This system also remembers the 
pathogen and can prevent it from causing disease later, in other words immunity is 
attained. The two key features of the adaptive or specific immune system are specificity 
and memory, both of which are not part of the innate immune system.  
Both of these systems are extremely complex and consist of a variety of 
molecules and cells distributed throughout the body. The major cellular players are called 
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leukocytes or white blood cells (WBC’s).  These cells include T and B-lymphocytes, 
monocytes, macrophages, dendritic cells, neutrophils, basophils, eosinophils, innate 
lymphoid cells, mast cells, and natural killer cells all of which have very special functions 
related to host defense. The major soluble factors include antibody or immunoglobulin 
(Ig), interferon (IFN), interleukin (IL) and tumor necrosis factor (TNF) and chemokines.  
1a. Innate immunity 
Innate or non-specific immunity is the type of system that is protective of the 
body without being dependent on lymphocyte activation or the production of specific 
antibody molecules. The innate immune system does not require previous exposure to a 
pathogen to be effective, and unlike the specific immune system are innately present in 
the body from birth.  
The innate immune system has external as well as internal systems. The external 
defense is made up of things that are effective on body surfaces that are exposed to the 
external environment. These include the skin, eyes and mucous membranes.  
The skin is the most important external defense and the importance of it is made 
clear particularly in burn victims. The barrier of epithelial cells covers all the exterior 
surfaces of the body including the respiratory tract as well as the alimentary canal. The 
sweat glands just under the skin produce bactericidal as well as fungicidal substances. 
The eyes have a tearing mechanism that rid the eye of contaminants. The tears also 
contain lysozyme, which breaks down bacterial walls. In the oral cavity, the epithelial 
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cells produce saliva, which also contains lysozyme as well as glycolipids, which inhibit 
the attachment of bacteria to the oral cavity77.  
The respiratory tract is protected by the nasal hairs in the nostrils which filter out 
large particles, nasal secretions contain lysozyme as well as other antimicrobial 
substances. The respiratory tract also consists of a mucus membrane produced by the 
epithelial cells. This membrane prevents microbes from coming into contact with living 
tissue. Most bacteria as well as viruses need to attach to living cells to survive. In the 
respiratory tract, cilia are constantly beating, causing mucus to move upwards toward the 
oral cavity for disposal. In the lower portion of the respiratory tract alveolar cells like 
macrophages, move within the air sacs and scavenge for debris. These macrophages 
phagocytize or ingest microbes or particles that have made it past previous barriers77.  
The alimentary tract has many of the same innate external barriers like epithelial 
cell linings, mucus and secretions. The alimentary tract, specifically the stomach also 
benefits from low pH conditions as well as digestive secretions. The large intestine is 
home to a very robust and multilayered microbial flora. These beneficial microflora 
inhabit much of the epithelial linings and do not allow much room for new more 
dangerous pathogens to take hold84.  
Although these external defenses are effective at keeping out foreign pathogens,  
breaks or malfunctions in these external defenses can lead to a pathogen getting into the 
interior of the body and triggering the internal aspects of the innate immune system as 
well as the adaptive arm. Despite the myriad of external defenses, many pathogens have 
adapted and developed ways to attack even healthy immune systems.  
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 The internal innate immune system consists of cells capable of ingesting and 
killing pathogens as well as some soluble factors, which can lyse as well as coat 
pathogens making them recognizable and easily degraded. Factors such as acute phase 
proteins as well as C reactive proteins and complement can facilitate the removal of 
foreign pathogens. Neutrophils as well as macrophages function to phagocytize foreign 
pathogens, specifically fungi and bacteria. Macrophages can also work to function as 
antigen presenting cells (APC) to provide information to T cells for future use84.  
1b. Adaptive Immunity 
The adaptive immune system has 3 main criteria that separate it from the innate 
immune system: preferential attack on ‘non-self’ over ‘self’, specificity, and memory.  
The ability to identify self from non-self results from the ability of T and B lymphocytes 
to recognize certain molecular configurations (antigens) either on the surface of the cell 
or pathogen or internal to the cell or pathogen.  On B-lymphocytes, the receptors that can 
carry out this recognition are molecules called antibodies or immunoglobulins (Ig’s), 
which are present on the surface of lymphocytes  (B cells) in the form of receptors.  The 
immunity that counts on body fluids containing Ig’s is referred to as humoral immunity, 
whereas those involving the T cells and their receptors is called cell-mediated immunity. 
T cells become stimulated by peptides from foreign antigens, which are displayed by the 
MHC molecules on the surface of either infected cells, or cells which have processed the 
antigen for presentation. CD8 T cells recognize peptides from the cytosol, which are, 
bound to MHC class I, while CD4 T cells recognize peptides generated in intracellular 
vesicles and displayed by MHC class II molecules84.  The adaptive immune system also 
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has memory because once it has come in contact with a given antigen it will respond 
quicker and to a greater degree upon subsequent exposure to that same antigen. This idea 
of greater and faster response of a secondary exposure is the basis for immunizations 84 
106.  
Both T cells and B cells are activated when they bind their specific antigen in the 
presence of accessory cells; the resting lymphocytes then proliferate and mature into 
effector and memory cells. This selection through antigen recognition results in the 
expansion of specific clones of either T cells with specific T cell receptors for the 
processed antigen on their surface, or B cells, which become plasma cells once they 
produce Ig, are coated with Ig specific to the stimulating antigen. Thus when 
reintroduction of the antigen occurs a much larger number of cells are ready to attack the 
pathogen 84.  
The Ig’s are a group of glycoproteins that are present in the serum and tissue 
fluids of all mammals. They are produced in large amounts by plasma cells that have 
developed from their B cell precursor. Each Ig molecule has a dual function; one region 
of the molecule is concerned with binding to the antigen, while a different region 
mediates the binding to the host tissues, including various immune cells, phagocytic cells 
and complement components. There are 5 distinct classes or groups of Ig’s (IgG, IgM, 
IgA, IgD and IgE), with varying sizes, charges, amino acid compositions and 
carbohydrate content.  
IgG is the major Ig and it accounts for ~75% of the total Ig in human serum and is 
the major antibody of the secondary immune response. IgM accounts for ~10% of total Ig 
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and is characterized by an increased number of binding sites and is mostly contained in 
the intravasculature. IgM is the predominant antibody in early infection. IgA account for 
~20% of human serum Ig and is the most prevalent Ig in mucous secretions. IgD is found 
only in very small quantities <1% of total Ig in serum. It is mostly found in the plasma 
membranes of B cells. Its role is thought to be the signal B cells to be activated. IgE is 
also found in very small amounts in serum, but is found attached to the FcR on the 
surface of basophils and mast cells and it is typically associated with hypersensitivity 
reaction or allergies 84. 
The response in which Ig’s play a pivotal role is in cell-mediated immunity and 
typically involves T cells, APC’s, and the activation of various immune cells. APC’s, 
including macrophages and dendritic cells (DC’s), process and present antigen to helper 
T cells (Th), which can only recognize processed antigen in the presence of Class II 
Major Histocompatibility Complex (MHC) present on APC’s. The Th cells are a central 
part of cell-mediated immunity, because they can modulate the action of a variety of 
other effector cells through the production of interleukins, interferons and other 
stimulating and inhibitory factors. These effector cells, macrophages, NK cells, cytotoxic 
T cells (Tc), granulocytes and B cells all perform a variety of effector functions in the 
fight against foreign pathogens.  
Many of these specific cell types as well as effector molecules will be discussed 
in further detail as they relate to exercise and influenza infection specifically.  
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2. Influenza Viral Infection 
 Influenza and resultant pneumonia has become a top ten leading cause of death 
among American adults, more than 36,000 Americans died from influenza infections in 
2012. This number is greatest among the elderly and understanding the mechanisms by 
which influenza infects humans is important in creating better vaccines as well as 
working to prevent dangerous outbreaks each year. This portion of the literature review 
will cover influenza viruses. Information on virus structure, attachment, replication, and 
mutations in the context of antigenic shift and drift will be discussed. This will be done 
by first discussion the makeup of influenza virus then looking at how influenza mutates 
and changes from year to year in a section about antigenic shift and antigenic drift.  
Viruses of the family Orthomyxoviridae are considered negative sense, single 
stranded segmented RNA viruses. The Orthomyxoviridae family contains the viruses 
thogotovirus, isavirus as well as the three types of influenza viruses, types A, B and C. 
Influenza A viruses are the main causative agent of severe respiratory tract infections 
which can elicit a wide range of symptoms. Symptoms can range from no symptoms, 
during the initial stages of viral shedding, to more severe symptoms including fever, 
chills, malaise, rhinitis and sore throat. During the typical Influenza A virus (IAV) 
infection, viral shedding can last for a period of 1 week to up to several months. In severe 
cases, hospitalization may be required and can be fatal due to the damage caused by the 
body’s immune response to the virus15. This damage can also lead to decreased immunity 
and subsequent secondary infections, like pneumonia, which often are the final cause of 
death. During IAV infection the lung may experience epithelial cell damage and along 
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with  the increase in immune cell infiltration there may be reduced gas exchange as well 
as reduced lung function.  
All influenza viruses have a very high mutation rate, which makes developing an 
effective vaccine each year difficult. Each year the strain as well as the severity of 
influenza changes, the World Health Organization (WHO) monitors the number and 
types of influenza cases worldwide. The predominant strains of influenza are evaluated 
by the WHO annually to predict which specific influenza strains will be most likely to 
infect the population the following year 83, 102, 134. A yearly vaccine is developed 
containing one influenza B virus strain and 2 influenza A virus strains, typically an H1N1 
and an H3N2. This past year, 2012-2013 the seasonal influenza vaccine contained, H1N1 
strain (A/California/7/09), H3N2 strain (A/Victoria/361/2011), and a B strain 
(B/Wisconsin/1/2010)2.   
2a. Antigenic Shift and Antigenic Drift 
In the spring of 2009, a novel strain of Influenza A began infecting people that 
resulted in a subsequent pandemic. In response to the pandemic the WHO encouraged the 
development of a vaccine to this specific H1N1 strain (A/California/7/09), which was 
separate from the seasonal vaccine124. The virus was isolated in the spring of 2009 and it 
was determined that the 2009 strain of H1N1 was a reassortment of past avian, swine 
human viruses. Reassortment occurs when two similar viruses that are infecting the same 
cell exchange genetic material. In influenza, whose genome consists of eight distinct 
segments of RNA, these segments act almost like mini chromosomes and each flu virus 
provides a single copy of their segment. The NA and M gene segments of the 2009 virus 
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were from the European avian-like H1N1 virus and the HA, NP and NS gene segments 
coming from the 1918 swine H1N1 virus, the PB2 and PA segments were from a 
different avian influenza A virus and the PB1 segment was from a seasonal human H3N2 
virus 127. This specific case is an ideal example to show how influenza viruses are able to 
reassort and mix in various hosts leading to what is known as antigenic shift. Antigenic 
shift is the process by which multiple different strains of a virus or multiple viruses 
combine within a common host to form a new and different subtype consisting of a 
mixture of the RNA genome, often resulting in expression of different surface antigens 
derived from the combining viruses 130. On the other hand, antigenic drift consists of 
point mutations which arise and alter the amino acid sequence of the HA structural 
components for example. As these small point mutations start to accumulate , the 
implications are that the anti influenza antibody which has developed will no longer be 
able to neutralize the virus via interaction with the HA protein51.   
These types of situations and findings point out how important it is to develop a 
protective annual vaccine that will fit the most common circulating strains, but it is also 
important to realize that it may not be possible to predict with 100% accuracy what 
strains and/or point mutations may arise.. This is why it is important to find additional 
means of enhancing host immunity, and/or find ways to boost response to a seasonal or 
pandemic strain vaccine. Being able to encourage healthy behaviors which are beneficial 
regardless of influenza strain or vaccine type will be essential in limiting the number of 
influenza related illnesses and deaths each year.  
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3. Lifecycle of the Influenza A Virus  
 3.1 Influenza Structure 
 The influenza virion is a roughly spherical, enveloped virus with glycoprotein 
spikes embedded into the lipid membrane, known as HA (hemagglutinin) and NA 
(neuraminidase) in a ratio of approximately four to one. These proteins determine the 
subtype of influenza virus137. There are currently 16 known HA subtypes46 and 9 NA 
subtypes. Also embedded in the lipid membrane is the M2 protein, with an M2:HA ratio 
of one M2 channel per 100-1000 HA molecules 145. Beneath the lipid membrane is a viral 
protein called M1 or matrix protein. The genome of the influenza A virus contains 
segmented, single-stranded RNA of negative polarity. The eight RNA segments code for 
the viral proteins PB1,	  PB2,	  PA,	  HA,	  NA,	  M1,	  M2,	  NS1	  and	  NP	  proteins77.	  The	  interior	  of	  the	  virion	  also	  contains	  another	  protein	  called	  the	  NS2	  or	  NEP	  (viral	  nuclear	  export	  protein).	  The	  single	  stranded	  RNAs	  are	  associated	  with	  multiple	  monomers	  of	  nucleoprotein	  (NP)	  and	  a	  single	  copy	  of	  the	  polymerase,	  which	  is	  a	  heterotrimer,	  composed	  of	  the	  PB1,	  PB2	  and	  PA	  subunits.	  This	  whole	  unit	  is	  called	  a	  ribonucleoprotein	  (RNP)	  particle.	  Such	  RNPs	  are	  independent	  molecular	  machines	  responsible	  for	  transcription	  and	  replication	  of	  each	  virus	  gene.	  The	  M1	  protein	  forms	  a	  layer	  to	  separate	  the	  RNP	  (Ribonucleoprotein)	  from	  the	  viral	  membrane77.	  This	  protein,	  which	  forms	  a	  shell,	  gives	  strength	  and	  rigidity	  to	  the	  lipid	  envelope	  and	  may	  be	  required	  for	  viral	  budding. The HA and NA proteins are on the 
surface of the virus and are the primary target for the hosts immune system. This includes 
the antibody which is the primary protection provided by immunization.  
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 3.2 Viral Attachment 
The various strains of influenza are defined by the number of the HA and NA 
protein that correspond to that specific virus, for example H3N2. This would indicate that 
the virus expresses the hemagglutinin 3 protein and the neuraminidase 2 protein on the 
surface. The HA glycoprotein is typically the dominant component of the external surface 
with about a 4:1 ratio of HA to NA77.  In influenza the HA glycoprotein interacts with the 
sialic acid receptor on the respiratory epithelial cells41. The interaction between the HA 
and the SA receptor provides the virus with access to the hosts cytoplasm, where it begins 
to replicate31, 116, 132.  
 Sialic acid (SA) residues are present on glycoproteins and glycolipids which are 
expressed on many cell types in the human body, however there are varying 
configurations of SA residues (α-2,3 and α-2,6 linkage) that can help explain why some 
human influenza strains do not infect other species and why certain species strains do not 
infect humans20.  It has been determined by multiple groups that human seasonal 
influenza A virus HA protein preferentially recognizes α -2,6 linkage, which is expressed 
on upper respiratory tract epithelium of humans. The H5N1 (avian) strains prefer the α -
2,3 linkage for attachment. The α -2,3 linkage is more localized on the ciliated cells of the 
lower respiratory tract in humans 115, 132. The lower ciliated airway epithelial cells only 
account for a very minor portion of the cells in the airway. The more dominant type of 
upper respiratory airway cells express the α -2,6 linkage and this may provide reason why 
humans are more susceptible to the seasonal IAV38, 115.   
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3.3 Viral Entry 
Influenza A virus most often attaches to the respiratory epithelium of its human 
host, once attachment has occurred, viral entry occurs through a pH dependent fusion 
process. IAV requires an environment with a low pH to initiate fusion with the plasma 
membrane; this fusion produces the formation of an endosomal compartment. Entry of 
the virus into the cell can occur through one of 4 possible pathways: the formation of 
calveolae, clathrin-mediated endocytosis, clathrin-independent endocytosis and 
macropinocytosis29, 30, 48, 82.   Research has shown that the clathrin-mediated endocytic 
pathway is the most common form of viral entry by influenza virus 21, 62.  Briefly, 
clathrin-mediated endocytosis occurs when numerous HA proteins interact with 
glycoproteins. Clathrin coated pits are formed, these deepen into the plasma membrane 
and eventually pull away into the inner portion of the cell48, 119. The virus is now 
internalized in a clathrin-coated vesicle that is uncoated and then fuses with a more acidic 
endocytic vesicle. The acidic environment of this vesicle induces further action by matrix 
2 protein, which acts as an ion channel pump, this acidic activity causes the HA proteins 
to go through a conformational change, which leads to fusion of the virus and endosomal 
membrane and subsequent release of viral ribonucleoprotein complexes (vRNPC) into the 
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3.4 Viral Replication 
Once the IAV has reached the endosomal compartment and the uncoating has 
occurred, vRNPC are taken up through nuclear pores. Once in the host nucleus, 
replication and transcription are thought to occur simultaneously. A process called cap-
snatching initiates the transcription process and host mRNA is cleaved by PB2 and then 
used by the viral polymerase as the transcription primer. Viral mRNA has been shown to 
be synthesized in both an early and late phase. During the first phase of protein 
production, all eight of the genomic sequences are translated by the host cell15. In 
subsequent phases, other necessary proteins are formed, then M1 protein binds to the 
newly produced vRNPs and exports them from the host cell nucleus. The new virion will 
not be fully formed until it begins to bud off from the host cell15.   
3.5 Viral Release 
Final assembly of the virus occurs on the surface of influenza-infected cells near 
lipid rafts. It appears the HA and NA molecules need to be near these lipid rafts for viral 
budding to occur, however this is still a topic of research. The viral budding is initiated 
by the HA molecule inducing a curvature on the outside of the host cell which causes the 
initial budding and then pinching off of the newly formed virion109.   This process of viral 
uptake and then release of newly formed virions occurs over and over until host immune 
cells overtake the virus or the host can no longer survive.  
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4. Immune response to influenza infection 
 As we have seen from the sections above, the immune system is a very elaborate 
system with countless cells, proteins and molecules that work together to keep the body 
free of foreign invaders and pathogens. The body has developed a very robust response to 
viral invaders, which starts with the innate immune system and is carried on into the 
adaptive immune system. The next several sections will discuss how the immune system 
responds specifically to influenza infection. This section will also go more in depth about 
specific immune cells and how they help in the response to influenza infection.  
4.1 Innate immune response to influenza virus infection 
As mentioned before, one of the first lines of defense against in infection is a 
layer of mucus in the respiratory tract. This mucus is constantly being moved up and out 
of the lungs and throat. The mucus layer also contains various proteins including, mucins, 
defensins, lectins and collectins, many of these proteins become upregulated during 
influenza infection13, 110.  These proteins also act by binding to and coating pathogens 
leading them to be neutralized. If the host has previously come in contact with this strain 
of IAV, the antibody associated with the mucus can provide protection by opsonizing and 
neutralizing the virus and preventing it from further infecting respiratory epithelium126.  
If IAV infection occurs, the respiratory epithelial cells are typically the first cells 
to become infected.  These virally infected cells are recognized by macrophages or NK 
cells as well as other innate cells that are able to recognize infected cells.  Cells are able 
to recognize virus through intracellular immune receptors referred to as pattern 
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recognition receptors (PRR) like TLR-7 and RIG-I. Innate immune cells are not the only 
cells capable of recognizing viral infection; epithelial cells as well as adaptive immune 
cells are a few examples that will be discussed later.  
4.1a TLR’s 
Toll-like receptors (TLRs) are in a family of proteins that are able to recognize 
pathogen associated molecular patterns (PAMPs) and help to initiate the host innate 
immune response. TLRs have extracellular repeats that are able to recognize and bind to 
their specific PAMPs as well as a transmembrane domain and an intracellular domain. 
The intracellular interact with certain adaptor proteins, which in turn activate downstream 
signaling pathways. There are 10 current TLRs in humans with each detecting a different 
and distinct PAMP. They are present on many nucleated cells and are up regulated in 
response to pathogens and certain cytokines. 91.  Toll like receptors, TLR3, TLR7, TLR8 
and TLR9 are able to recognize viral genomic material. TLR3 recognizes double stranded 
RNA, TLR7 and TLR8 recognize single stranded RNA74, and TLR 9 senses 
unmethylated DNA with CpG motifs. TLR 7 and TLR9 are expressed in large quantities 
on plasmacytoid dendritic cells (pDC). TLR 3 is expressed on conventional dendritic 
cells (cDC’s) and macrophages.  
 
4.1b Dendritic Cells 
Dendritic cells represent a family of immune cells that display numerous 
phenotypes.  This will be a short discussion on dendritic cells, with a major focus on 
plasmacytoid dendritic cells (pDC). 
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Dendritic cells survey the peripheral environments around the body, and as their 
name suggests, these cells possess finger-like protrusions (dendrites) across their surface 
123.  These dendrites increase the surface area of the cell thereby increasing the chances 
for antigen exposure in the peripheral environment.  These dendrites can also fit through 
tight junctions between epithelial cells increasing access to pathogens on the luminal side 
that have yet to cross the epithelial cell layer, and this is one way antigen in the gut and 
alveoli of the mucosal environments is acquired by these cells.  Phagocytosis occurs once 
an antigen of interest is encountered. Phagocytosis and signaling through TLRs initiates 
migration towards secondary lymphoid tissue. 
Dendritic cells acquire antigen deposited by infection or vaccination and deliver it 
to the draining lymph node to interact with its corresponding T cell 8, 9. Plasmacytoid 
dendritic cells are a unique subset of dendritic cells that function minimally in the process 
of antigen presentation. Instead, pDC’s are well-known for their potent production of 
type-I interferons (mostly IFNα, but also IFNβ) after coming in contact with viral RNA 
and CpG oligodeoxynucleotide through their receptors TLR 7 (ssRNA) and TLR 9 
(DNA) 52, 70.  Interferon-α in particular, works by activating a complex antiviral response 
that may limit viral replication during infection if sufficient levels of IFNα are produced.  
In aging populations, reductions in circulating numbers of pDC have been identified 
along with reductions in the amount of IFNα produced by pDC 117.  The reduction in 
IFNα is thought to be due to a reduced expression of TLRs on pDC, leading to reduced 
stimulation of TLR by inactivated virus, 3, 14, 95, 129.  Although the pDC subset of dendritic 
cells represent a relatively small number of dendritic cells, their dysfunctions are very 
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likely to contribute significantly to the age-associated declines of other immune cells. 
Dysfunction in pDC can lead to a dysfunction in production of IFNα, which is important 
in the upregulation of MHC class I on antigen presenting cells and subsequent B and T 
cell function. 
4.1c IFNs 
Interferons (IFNs) are a type of cytokine that is secreted by host cells in a 
response to viral pathogens including IAV. IFNs are typically classified into 3 types, IFN 
I, II and III. Type I interferons IFNα and IFNβ, bind to specific cell surface receptor 
complexes known as the IFNα receptor. In humans type I interferons consist of IFNα 
which has 13 subtypes, IFNβ and IFNω. Interferon type II or IFNγ has 3 subtypes and 
binds to IFNγ receptors. The type III interferons (IFNλ) binds to IFNλ receptors 4.  
Once virally specific PRR’s such as TLR3, 7, 9 and RIG I are activated, they can 
stimulate the production of type I IFN. In the case of IAV infection type I IFNs are 
secreted by pDCs, alveolar macrophages and infected epithelial cells 53. These type I 
IFNs work by up regulating the transcription of a number of IFN inducible genes. Some 
of these genes include transcription factors which creates an amplification loop, while 
other IFN inducible genes produce proteins that influence protein synthesis, growth arrest 
and apoptosis which creates an antiviral state40. Type I IFNs have other 
immunomodulatory roles, that may be important in activating the immune system 
including: dendritic cell maturation, natural killer cell activation, antibody production and 
the differentiation of virus specific T cells.  
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Natural killer cells are recruited to the site of infection and immediately begin 
killing infected cells through cytotoxic activity, in response to type I IFN stimulation104.   
Neutrophils also will migrate to the site of infection and help to engulf cells which have 
been opsonized with antibody49. Neutrophils are not particularly known for their immune 
response to influenza infection but can play a role28, 36, pDC on the other hand have been 
recently shown to be involved in a successful response to IAV infection. As noted earlier, 
pDC produce large amounts of IFNα, which has been touched on numerous times already 
in this, review47.   
Dendritic cells also work to eliminate influenza infection as well as bridge the gap 
between the innate and adaptive immune systems.  Even before infection, DCs work by 
sampling debris and cells within the respiratory environment. If a DC sense a pathogen 
via a PRR, they uptake the antigen, process it and then work by migrating to a draining 
lymph node. At this point the DC matures and increases expression of MHC I and MHC 
II molecules, these along with co stimulatory molecule CD80 and CD86 activate the 
adaptive immune system84.  
 
4.2 Adaptive immune response to influenza infection 
 Communication between the innate and adaptive systems is carried out with the 
help of cytokines that bind to cells, and by cell- cell interactions like the one between 
DC’s and lymphocytes. Antigen presenting cells (APCs) such as DC’s acquire cytosolic 
viral antigens through the MHC I molecule, and extracellular viral antigen through 
phagocytosis. The extracellular antigens are presented on MHC II molecules in a process 
called antigen presentation. Upon stimulation with microbial products, inflammatory 
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cytokines or CD40 ligation, DCs start to mature and migrate to the draining lymph nodes. 
Maturation of DCs is associated with phenotypic changes including down-regulation of 
phagocytic capacity, up-regulation of costimulatory molecules, MHC and secretion of 
cytokines. This process transforms them into fully functional APCs capable of priming 
naïve T cells through presentation of antigen on MHC molecules77.  
The MHC I and MHC II molecules are recognized by the receptors on CD8+ T 
cells and CD4+ T helper (Th) cells, respectively. Recognition of antigens presented on 
MHC I of APCs by the T cell receptor, a second signal via costimulatory molecule 
CD80/86 on APCs interacting with CD28 on naïve T cells and cytokines such as IL2 are 
required to activate the T cell. The naïve CD8+ T cells that recognize influenza antigen 
and express CD28 then begin the process of clonal expansion. The effector CD8+ T cells 
or cytotoxic T lymphocytes (CTLs) return to the lung in a phenomenon called cellular 
homing, possibly via CD27 50. They recognize influenza infected cells via their T cell 
receptor and kill those cells by producing IFNγ (type II IFN) and directed release of 
perforin and granzymes. IL-12 secreted by cDCs is essential for CTLs to produce IFNγ, 
which activates other immune cells (for example increases phagocytic activity by 
macrophages) and drives activated B cells to produce highly specific anti-influenza 
antibody.  CTLs serve a cytotoxic function by producing perforin and granzymes 
specifically in response to influenza virus infected cells which express the influenza 
peptides and MHC I complex on their surface. The CTLs require the help of Th cells, as 
reviewed next. 
 Naïve CD4+ T cells are activated in a similar way by T cell receptor ligation to 
antigen presented on MHC II of APCs and costimulation. However, they are not involved 
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in cytolytic killing but play a vital role in activation of influenza-specific B cells. Until 
recently, it was thought that two types of effector CD4+ Th cell responses can be induced 
by a professional APC, designated Th1 and Th2. However, recently many other subsets 
of Th cells have been discovered. Th cell subset development is dependent on the 
cytokines that the cell is exposed to and the transcription factors that are expressed in the 
cell. Each subset produces a different set of cytokines and has various functions in the 
body. In general Th1 responses are more effective against intracellular pathogens such as 
influenza virus, while Th2 responses are more effective against extracellular bacteria and 
Th17 against parasites and toxins. Influenza virus specific immunity relies on the 
activation of both CD8+ and CD4+ T cells, as CTLs are required to eliminate infected 
cells and B cells stimulated by CD4+ T cells produce anti-influenza virus antibody 
necessary for the host to overcome this infection. 
 Naïve B cells express MHCII molecule and can present antigen. They are 
activated by Th cells that respond to the same antigen and induce differentiation into 
antibody producing plasma cells, which can produce high levels of antibody. IgA, IgG 
and IgM are all produced during primary infection. IgA and IgM are found 
predominantly in the infected mucosal tissue and IgG is prevalent in the serum. There are 
multiple subtypes of IgG, and these vary by species. Subsequent infection leads to 
antibody production of increased specificity, and all three antibody isotypes can be found 
in the serum. IgM and IgG antibodies can be produced by Th cell dependent or 
independent routes, and are vital to the immune response against influenza virus 66. 
Antibodies can neutralize viral infectivity by blocking uptake into cells, preventing 
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uncoating of the genomes in endosomes, interfering with virion binding to receptors, or 
causing aggregation of virus particles.  
 One of the most important aspects of the adaptive immune system is the 
formation of ‘memory’ cells. When B and T cells are activated and undergo clonal 
expansion, some of these cells become memory cells. When they interact with a 
previously encountered antigen, the appropriate memory cells are selected and activated.  
 The idea of a memory response and response to influenza virus infection leads to 
the topic of ‘original antigenic sin’. Often when a pandemic strain of influenza emerges, 
there are characteristics or structural similarities between old viruses and this newer 
strain. Again for example, the 2009 H1N1 virus quickly emerged and it was shown to 
contain some of the same characteristics of past H1N1 viruses. The idea of ‘original 
antigenic sin’ is important because it lends to the idea that regardless of subsequent 
strains of influenza that an individual will encounter later life, the first strain they 
encounter in life is the one they develop a dominant anti-influenza antibody response. 
The HA molecule on the surface of the virus is the main target for anti-influenza 
antibody, and aged individuals may have some protective memory from past exposures 
75.  This is one reason by the 2009 H1N1 was so dangerous to younger people, because it 
was completely novel to their immune systems. Upon each subsequent exposure to 
influenza virus infection, they will only further develop more of that one type of HA-
specific antibody, which would only be protective if the host encounters a virus 
expressing the same HA, molecule as the previously encountered strain.  This is the main 
dilemma highlighted by the idea of ‘original antigen sin’ and it shows the importance of 
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vaccination strategies that lead to development of memory T cell responses, which target 
conserved structural components among influenza virus strains, in addition to antibody.  
5. Immune responses to stress 
 As mentioned earlier, there is a strong connection between the immune system 
and neuroendocrine factors. Particularly those neuroendocrine factors that are activated during	  physical	  or	  psychological	  stress	  and	  affect	  immune	  response. The psychological 
response to stress also ends up having a physiological effect. The effects of psychosocial 
factors on immune function have been extensively studied and are the topic of many 
reviews 5, 80, 111, 112.  As an example of these interactions, several studies have indicated a 
drop in total white blood cells among stressed individuals compared to those who are 
experience low levels of psychological stress 67. Chronic psychological stress has been 
shown to have an effect on the numbers and ratios of T cells in the body. Studies have 
also shown that the percentage of T cells is decreased in stressed individuals versus 
matched controls 96. It has been reported that depression leads to effects on the immune 
system. For example, there is evidence that those suffering from depression also have a 
reduced neutrophil function 32 as well as decreased T cytotoxic cell and NK cell 
activity103.  Again, these are several examples of the well-documented effects of stress 
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6. Vaccination 
There are currently two types of vaccines used against influenza, an injectable 
(intramuscular) flu shot and a nasal spray. The flu shot consists of inactivated (killed) 
influenza virus, given intramuscularly and approved for use in higher doses for people 65 
and older. The live attenuated vaccine consists of the same three strains of live, 
attenuated virus and is given by an intranasal dose to people between the ages of 2 to 49 
years of age 17.The high dose vaccine contains 4 times the amount of antigen contained in 
regular flu shots 16. Current regular influenza vaccines contain 15 µg of the 
hemagglutinin of A/H1N1, A/H3N2, and B strains, respectively, and are administered to 
induce serum anti-hemagglutinin antibody (IgG’s) for prevention of subsequent infection 
and illness from natural influenza. The high dose vaccines were developed to meet the 
need for a higher efficiency vaccine for the elderly populations. The efficacy of the 
regular trivalent inactivated influenza vaccine responses in individuals above 65 years of 
age were reduced compared to young individuals 64. A large study performed in the 
Netherlands during the 1991-1992 influenza season reported that the effectiveness of the 
influenza vaccine decreased with increasing age groups (57% in people aged 60–69 years 
and 23% in volunteers aged ≥70 years) 46. New strategies to improve the response to 
vaccinations in the elderly are still being developed at present.  
 
6.1 Vaccine adjuvants 
Although vaccines can provide the body with a pre warning against an impending 
or possible infection, they do not always reach their full potential in all populations. 
Finding ways to boost this vaccine response is critical to give protection to the largest 
	  	   28	  
group of people. One way to boost the vaccine response is through the addition of 
adjuvants. In the most basic terms an adjuvant is something that enhances the immune 
response to antigen. The adjuvants are typically added to create a more rigorous response 
by the immune system and thus increased immunity to the target pathogen. The presence 
of adjuvant often works by increasing the innate immune response by augmenting the 
activities of DCs and macrophages and mimicking the natural infection. Adjuvants can be 
included in the vaccine or can be given after vaccination has occurred. The most common 
forms of adjuvant are chemicals, macromolecules, or immune cells, examples include 
aluminum hydroxide and paraffin oil25, 78.  However, there are currently no adjuvants 
approved by the FDA for use in seasonal influenza vaccine in the U.S.  Studies have also 
shown that Type I interferons, including IFNα may have some adjuvant activity in an 
influenza model12, 101.  
 
 6.2 Stress and vaccine response 
 The body’s ability to respond to a vaccine is directly related to the health of the 
immune system. As we have discussed in previous sections, the health of the immune 
system can be tied to both physiological health as well as psychological health. A few 
different studies have shown how stressful environments can have effects on the response 
to vaccination. One of these studies looked at caregivers for Alzheimer’s patients, the 
caregivers had reduced antibody responses to vaccination as well as a decline in virus 
specific T cells compared to non caregiver controls 54. A similar study compared those 
who had suffered stressful careers earlier in life to those who were currently in a stressful 
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workplace. Those who were currently in a stressful workplace had significantly lower 
antibody responses to vaccine compared to those who were no longer in the stressful 
situation 43. This may indicate that the immune system is able to recover from stressful 
situations and that stress does not permanently damper immune response to vaccination.  
 
7.  Exercise Immunology 
The field of exercise immunology is relatively new when compared to other fields 
of biology. Despite its relative infancy, there have been studies involving physical 
activity and immunity as far back as 100 years ago114.  Beginning findings of an 
increased incidence of upper respiratory tract infections in elite athletes or people training 
for endurance type events really pushed the development of this specific field. In these 
early stages of exercise immunology, it appeared that excessive exercise could lead to a 
negative impact on immune function. However, the idea that regular moderate exercise 
may have beneficial effects on immune responsiveness was not a very large area of focus. 
This is changing however, as more and more research is showing a positive relationship 
between immune health and moderate exercise24, 55, 57, 72. Physical activity has been 
related to a lower risk of developing cardiovascular disease, hypertension, infectious 
illnesses, diabetes and cancer. In addition, other physical and mental type interventions 
like yoga have been shown to possibly improve both physical and mental health7, 108.  
The immune systems response to exercise seems to depend on not only the 
duration but the intensity of exercise being performed. In the early days of exercise 
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immunology, David Neiman proposed a model to better show the relationship between 
exercise and the risk of respiratory tract infections (URTI), this was referred to as the J 
curve 88 (Fig 1).  The idea behind this model is that at a level of no or very low intensity 
exercise there is an increased risk of respiratory tract infection, there is also an increase in 
risk of URTI with high intensity or very long duration exercise. Moderate intensity 
exercise on the other hand minimizes the risk of URTI. Several types of research 
indirectly support this idea that moderate exercise is helpful but exhaustive exercise is 
harmful with regards to the immune system. It is well known that a variety of stressors if 
given in a sufficiently demanding level can affect human and animal immune responses. 
Studies have supported the concept that although acute exposure to an intense stressor 
can suppress immunity, repeated exposures can result in adaptation of the host to the 
stressor. The duration and intensity of exercise are important in analyzing immune 
responses to exercise, it is also important to understand how exercise effects the two arms 
of the immune system differently.  
7.1 Exercise and innate immunity 
Exercise has been shown to have effects on various aspects of the innate immune 
system. Neutrophilia has been shown shortly after the onset of exercise and an additional 
round of neutrophil influx into the blood occurs after the exercise has ceased. This 
secondary neutrophilia seems to be dose dependent on both intensity and duration of 
exercise. Despite this increase in neutrophils in circulation, several studies have shown a 
decreased degranulation and a decreased oxidative burst when these cells are stimulated 
by pathogen 97, 98, 105.  While these studies show neutrophilia in response to an acute bout 
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of exercise, it has also been shown that regular exercise training can have an even greater 
effect on neutrophils, as respiratory burst has been shown to be decreased up to several 
days post exercise125.  Studies in animals have shown how exercise affects tissue specific 
macrophages. Moderate intensity exercise as well as high intensity exercise stimulated 
the phagocytic function of these macrophages and chemotaxis were altered in response to 
corticosterone production92, 93.  Studies have also shown decreases to macrophage MHC-
II expression along with a decrease in antigen presentation during and after exhaustive 
exercise 18, 19, 135.   
Lastly, only a handful of studies have looked at how exercise affects dendritic cell 
number and function. One of these studies showed an increase in the number of DC cells 
in response to exercise training68.  The other showed an increased expression of MHC-
class II along with increased production of IL-2 in exercise trained animals23.  There are 
also a limited number of studies looking at the effects of exercise on DC subpopulations, 
particularly pDC. One study by Nickel showed a decrease in the number of circulating 
pDCs after a marathon86, but did not look at pDC functionality. On the contrary, another 
study looking at intense short duration exercise, found that the numbers of circulating 
pDC were increased post exercise. This same study also found a strong correlation 
between the increase in pDC numbers and the increase in plasma epinephrine and 
norepinephrine 124. Finally, a study done in athletes performing Tai Chi, found no 
difference in circulating pDC in the exercising group versus the sedentary control 22. 
These studies seem to point to the idea that exhaustive long duration exercise such as 
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running a marathon may be detrimental to pDC numbers while short intense exercise may 
work to increase these numbers.  
Innate immune cell alterations seem to be mixed in response to exercise. These 
differences are most likely due to the varying duration and intensity of exercise used in 
each individual study. If we look at animal models of exercise and immune function, we 
can quickly notice the changes due to intensity and duration of exercise. A study looking 
at a bout of exhaustive exercise just prior to HSV-1 infection led to increased mortality58, 
A number of studies looking at moderate intensity exercise prior to influenza virus 
infection showed improvements in illness scores post infection120.  These varying results 
illustrate that the effect of exercise on a given immune response may be dependent upon 
intensity, dose, duration, and frequency of exercise, and therefore it is important to 
consider these factors when comparing the impact of exercise on immune function.   
 7.2 Exercise and adaptive immunity 
The adaptive immune system has also been shown to be altered in response to 
exercise. For example, shortly after the onset of exercise, lymphocyte numbers increase 
in circulation. But with respect to lymphocytes the numbers in circulation tend to 
decrease below baseline levels after the exercise has ceased. This decrease in the number 
of circulating lymphocytes (B and T cells) seems to correlate to the duration and intensity 
of the exercise and the amount of recovery between exercise sessions 81, 107, 113.   
While it has been shown that lymphocyte numbers can be reduced with exercise, 
the activation of T cells in response to antigenic stimulation was shown to be increased 
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using expression of activation markers on T cells 37, 39.  This points toward a change in 
adaptive immunity in response to exercise and it also suggests that despite a change in 
circulating cell numbers, their function may in fact be increased.  
7.3 Immune responses to acute bouts of exercise 
 Several studies have shown an increase in the risk and incidence of URTIs in 
marathon runners in the weeks following a big race or other similar long duration 
endurance events89, 100, while a few other studies seem to not see this same effect35. As 
noted earlier, in response to a single bout of intense exercise, there appears to be an 
increase in the numbers of naïve T cells, neutrophils and memory T cells, as well as many 
pro inflammatory cytokines including TNFα, IL1β, IL-6 and other inflammatory factors 
such as CRP and MIP-1 in the peripheral blood. This single bout of intense exercise can 
also cause a temporary increase in anti-inflammatory cytokines including IL10 and 
IL1RA 94. IL6 increases can be mostly accounted for by their release from contracting 
muscles 122.  Acute exercise has also been shown to increase circulating numbers of NK 
cells during exercise. As mentioned earlier, acute exercise also decreases the proliferative 
capacity of lymphocytes, MHC II expression, and antigen presenting activity of 
macrophages, but this effect is likely dependent on duration and intensity of exercise.  
7.4 Immune responses to chronic exercise 
  Most research that involves a chronic exercise training programs span 
approximately 8weeks up to 1 year. With this large range of exercise interventions it is 
often difficult to compare studies and outcomes. Most studies compare a trained or 
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training population to an untrained control. As the body ages, different aspects of the 
immune system become dysregulated and less effective. If a program of regular exercise 
can maintain optimal immune health into later life, it could help to prevent many diseases 
which arise due to an age weakened immune system.  
 One of the main areas, which have been studied in relation to chronic exercise 
training, is levels of non-specific antibody. Initial ideas in potential mechanisms that may 
explain the greater susceptibility of endurance-trained athletes to upper respiratory tract 
infection (URTI) included the role of salivary IgA.  Endurance-training athletes might be 
more susceptible to URTI related to levels of salivary IgA. Initial thoughts were that 
chronic endurance training led to a decrease in these non-specific antibodies and led to 
greater susceptibility to URTI. However, recent studies have shown no difference 
between trained endurance groups and untrained controls44, 90.  
 Regular moderate exercise has also been shown to decrease mortality to influenza 
infection in mice 73,  it also has been shown to improve antibody response to HSV-1 
infection in mice60, as well as responses to influenza vaccine in human subjects56, 136. 
Human subjects who exercise at a low to moderate intensity had a lower mortality rate to 
influenza or influenza associated infections as compared to those who did not exercise133. 
In an animal model, mice which performed regular moderate intensity exercise on a 
treadmill have a lower illness severity and a lower viral load in the lungs compared to 
mice who did not exercise121.  These findings demonstrate that exercise has the potential 
to lessen potential disease outcomes in several different models.  
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7.5 Immunity, exercise and neuroendocrine interactions 
 Many of the changes in immune response that occur during or after exercise are 
mediated through the neuroendocrine system. It has been shown that the immune system 
is able to communicate with the neuroendocrine system through common or related 
peptide hormones 10.  
 Generalized stress tends to elicit a similar neuroendocrine response in most 
people with release of hormones like ACTH, TSH, endorphins, catecholamines and 
certain steroid hormones. However in exercise, the neuroendocrine response is varied and 
changes depending on exercise conditions as well as subject training status 128. 
 In response to exercise, the hypothalamic-pituitary-adrenal axis is activated and 
hormonal changes occur11. This activation leads to increases in plasma concentrations of 
several hormones and neuroendocrine factors including the catecholamines epinephrine 
and norepinephrine, growth hormones, β-endorphins, estrogen, testosterone, prolactin and 
cortisol, all of which are known to possess immunomodulatory effects 61, 99. Lymphocytes 
have receptors for hormones and will respond to stimulation from a number of mediators 
including acetylcholine, norepinephrine, epinephrine, prostaglandins and histamines. 
Epinephrine has been shown to alter the number and proportions of lymphocytes27 and 
corticosteroids have been shown to prevent exercise induced lymphocytosis 137.  
Neutrophils, macrophages, T cells, B cells and NK cells all express β-adrenergic 
receptors that are targets of the catecholamines.  Based on some studies, epinephrine and 
cortisol may suppress Th1 cytokine production, although these effects are variable and 
depend on immune parameters being measured as well as the dose of these hormones.  
Other studies have shown that Th2 response mediated by IL-6 may also vary with 
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exposure to neuroendocrine factors79, 122. From this we can gather that the hormones and 
neuroendocrine factors produced during exercise work to may modulate the Th1/Th2 
cytokine balance63. While the decrease in Th1 due to epinephrine stimulation may be 
harmful in a case of viral URTI in endurance athletes, a shift toward Th2 due to IL6 
might prove to be beneficial by reducing the cellular damage and inflammation.  
 During prolonged exercise muscle derived IL6 seems to be partly responsible for 
the increase in secretion of cortisol, by stimulating ACTH in the anterior pituitary gland 
or by stimulating the release of cortisol from the adrenal glands45. 
Alterations in cell number and/or function during exercise may be due in part to 
the effects of epinephrine and other hormones that are produced in response to exercise. 
Other studies have also shown a decline in adaptive immune cell function in response to 
increases in stress hormones such as cortisol, which is typically elevated during exercise6, 
63.  There is mixed evidence of the effect of some of these neuroendocrine hormones on 
dendritic cells, specifically pDCs. A bout of high intensity exercise promoted an increase 
in pDC numbers, with a strong correlation to the increase in epinephrine and 
norepinephrine 124. While a separate study showed a decrease in IFNα production by pDC 
when treated with high dosages of epinephrine 26 But again it is important to remember 
that these changes are dose and intensity dependent as not all types of exercise cause 
immune cell depression.  
7.6 Exercise and Vaccination 
  An increasing number of studies are looking at the effects of exercise and the 
response to vaccination. Many of these studies suggest that exercise intervention can 
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improve the response to influenza vaccinations in both the young 33, 34 as well as the aged 
population 56. In a study conducted in older adults, long-term exercise intervention with 
regular moderate exercise increased antibody titers to the seasonal influenza vaccine. 
Studies in younger adults, found that a single session of intense exercise or acute mental 
stress could improve antibody titers in the female study subjects. However, a recent study 
showed that a single 45minute brisk walk did not have any effect on the antibody 
response to vaccine in both the young as well as older subjects and that a longer more 
intense bout of exercise may be necessary to improve vaccine response 71. This like many 
of the other studies using acute exercise put the exercise bout prior to vaccination. In a 
recent review examining vaccination and exercise, 20 studies were found, and nine of 
these examined the effect of acute exercise at the time of vaccination.  In the studies on 
acute exercise, the exercise was performed prior to vaccination (89) Further research is 
needed to determine if exercise can truly enhance vaccine efficacy and if so, it will be 
important to establish the appropriate type, duration and intensity of exercise as well as 
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Figures Chapter I 
Figure 1. 
 
Figure 1: Exercise and the J curve model first developed by Neiman 87 to show the 
relationship between the risk of infection and intensities of exercise. The model shows 
how the lowest risk of infection occurs when an individual participates in regular 
moderate exercise. While the highest risks of infection occur when one does no exercise 
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Abstract 
Epidemiological studies suggest that moderate exercise is associated with 
improved resistance to infection, although mechanisms remain unknown.  Conversely, it 
has also been shown that acute exhaustive exercise is associated with increased 
susceptibility to infection, particularly upper respiratory tract infections. The purpose of 
this study was to examine the effects of long duration exercise on virus-stimulated IFNα 
production by plasmacytoid dendritic cells (pDC’s), as well as the potential role of 
psychosocial factors in healthy young adults. IFNα production by pDC serves as an early 
anti-viral defense, yet the effects of exercise and psychosocial factors, which may vary 
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with exercise, on pDC function have not been evaluated. Moderate exercise may increase 
pDC IFN, providing protection against viral infection whereas exhaustive exercise may 
compromise pDC function resulting in increased susceptibility to infection.  Changes in 
psychosocial factors that occur with exercise and/or alterations of neuroendocrine factors 
may also influence pDC function. To test the hypothesis that moderate intensity exercise 
affects anti-influenza innate immune defense in humans, 22 young subjects exercised at 
~85% of ventilatory threshold (VT) (moderate intensity) for 90 or 180 minutes. Blood 
was collected pre and immediately post-exercise.  PBMC were isolated and pDC’s were 
separated.  pDC (>95% pure) were cultured with 1600 HA units of influenza A/PR/8/34 
virus for 18 hours. Supernatants were collected and assayed for IFN-alpha, via ELISA. 
Subjects also completed the POMS, ADACL and Beck psychological surveys. The 
results indicated that 90min of exercise at 85% VT caused ~4 fold increase in IFNα 
production by pDC cells collected immediately post-exercise, whereas IFNα production 
by cells collected after 180 minutes of exercise was significantly less than pre-exercise 
values. Significant increases in IFNα production were also seen in epinephrine and 
norepinephrine stimulated cells compared to media controls. Subjects experiencing the 
greatest declines in IFNα production also showed the greatest levels of fatigue during 
exercise and the greatest levels of depression pre exercise. In summary, the temporary 
exercise-induced increase in antiviral function by pDC’s may contribute to the reduction 
of infection observed in regular exercisers. Also the decrease in antiviral function by 
pDC’s after long duration exercise may explain some of the increased susceptibility to 
infection.  
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Key Words: dendritic cell; exercise; interferon; plasmacytoid dendritic cell 
 
1. Introduction 
 Plasmacytoid dendritic cells (pDC) are a subset of bloodborne dendritic cells 
important for combating viral infections.  Viral nucleic acids are sensed by pDC during 
endocytosis when viral nucleic acids bind to endosomal Toll-like receptors (TLR) TLR7 
and TLR9 (Gilliet et al., 2008).  Signaling through TLRs results in the production of 
type-I interferon’s such as interferon-α (IFNα) (Gilliet et al., 2008), a molecule that 
disrupts viral replication, through a signaling pathway apparently unique to pDC  
(Kaisho, 2010).  IFNα confers an antiviral state by inducing expression of numerous 
antiviral genes in neighboring cells.   IFNα also has multiple immumodulatory effects 
such as the induction of dendritic cell maturation, prolonged expansion of antigen-
specific CD8+ cells, and promotion of B cell antibody class switching that may 
subsequently result in improved viral clearance(Basler and Garcia-Sastre, 2002; 
Curtsinger et al., 2005; Heer et al., 2007; Honda et al., 2003; Le Bon et al., 2006). Thus, 
appropriate interferon production is a critical response in successful viral clearance. 
 Exercise is known to influence immune function but the effects vary with duration 
and intensity of exercise as well as host factors such as age (Walsh et al., 2011).  Regular, 
moderate exercise is generally associated with improved immune function, but acute, 
strenuous bouts of exercise (such as that associated with marathon or triathlon 
competition) are generally associated with temporary declines in immune function 
(Martin et al., 2009) and increases in inflammatory markers (Main et al., 2010) post-
exercise.  The most widely documented example of this is the increased incidence of 
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upper respiratory infections such as colds and flus post-acute exhaustive exercise in 
aerobic athletes (Martin et al., 2009; Nieman, 1995).   
 The effects of acute exercise on pDC are poorly understood.  In one study of 
sixteen male ice hockey players who engaged in one hour of intense practice, it was 
demonstrated that circulating numbers of pDC increased post-practice (Suchanek et al., 
2010).  By contrast, in a separate study of forty-seven male marathon runners, it was 
shown that pDC cell numbers in the circulation dropped significantly after the race but 
then rebounded 24 hours later as compared to baseline levels obtained from resting blood 
2-5 days prior (Nickel et al., 2012).  In contrast, myeloid dendritic cell numbers (mDC) 
increased post-exercise and then returned to baseline 24 hours later.  These effects were 
observed across marathoners of varying body composition and training programs.  Also, 
both TLR7 mRNA and protein isolated from circulating leukocytes (including pDC as 
well as many other cell types) followed a similar suppression and rebound pattern (Nickel 
et al., 2012).  Earlier studies examining the effects of acute exercise on human dendritic 
cell counts generally (and not pDC specifically) reported that total dendritic cell numbers 
increased in response to both a 5-min stair sprint (Edwards et al., 1984) and treadmill 
stress test (Ho et al., 2001). To the best of our knowledge, no one has yet examined the 
effects of acute, strenuous aerobic exercise on pDC effector function such as IFNα 
production. 
It is also unknown how neuroendocrine factors may influence pDC effector functions 
in the context of exercise.  In vitro studies have demonstrated that human pDC’s cultured 
with catecholamines (epinephrine or norepinephrine) and a type I interferon-stimulating 
compound (such as poly:IC, CpG DNA, and/or LPS), produce less IFN-α compared to 
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control (type I interferon-stimulating compound alone), suggesting catecholamines may 
down regulate pDC IFN-α production (Collado-Hidalgo et al., 2006; Hilbert et al., 2013). 
Exercise increases the production of catecholamines and other neuroendocrine factors 
such as cortisol (LaVoy et al., 2011) , and these neuroendocrine factors may exhibit 
immunosuppressive effects. (Du et al., 2012) (Morgado et al., 2012).  Therefore, it is 
possible that strenuous exercise may deleteriously affect pDC IFN production. 
Long duration exhaustive exercise results in the utilization of the body’s available 
metabolic fuels. Several studies have shown that athletes who exercise in a carbohydrate 
depleted state have a greater amount of circulating stress hormones as well as a decrease 
in several immune function indices (Gleeson et al., 2004). Replenishment of carbohydrate 
during prolonged exercise attenuated cortisol and cytokine changes that occurred in 
response to exercise(Nehlsen-Cannarella et al., 1997; Nieman et al., 2001). Other studies 
have indicated that animals on an energy-restricted diet had a decreased immune response 
to and a greater mortality rate in response to influenza infection (Gardner et al., 2011; 
Ritz et al., 2008). To our knowledge, it is not known whether changes in glucose 
availability during exercise could affect pDC IFNα production. 
 It is also important to consider the potential psychosocial aspects of prolonged 
exercise such as stress, mood, and fatigue that could potentially contribute to altered 
immune responsiveness. Although the effects of different stressors on immune function 
have been well-studied(Moynihan, 2003; Powell et al., 2011; Segerstrom, 2010), very 
limited information exists with respect to the influence of psychosocial factors on pDC 
function. In one study, the expression of antiviral genes induced by Type I IFN’s was 
reduced in a chronic stress situation (i.e. low socioeconomic status)(Powell et al., 2013). 
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However, this study did not evaluate actual plasmacytoid cell production of IFN, and 
instead relied on gene expression analysis.  Another study showed that stress resulted in 
increased IFNα expression in response to influenza virus, although it was not established 
whether pDC’s were the source of the IFN(Mays et al., 2012). To our knowledge, there 
are no published studies that have examined the impact of psychosocial factors pDC 
IFNα response to virus.   
The purpose of this investigation was to explore the effects exercise, neuroendocrine 
factors and psychosocial factors on pDC production of IFNα.  It was hypothesized that 
exhaustive exercise would be associated with reduction in pDC-produced IFNα and that 
pDC cells that were stimulated with the neuroendocrine factors epinephrine, 
norepinephrine and cortisol would show a decreased production of IFN-α compared to 
media controls. To test these hypotheses, in the first set of experiments, two groups of 
aerobically trained young adults exercised for 90 or 180 minutes on a cycle ergometer.  
Blood was collected before and after each exercise bout, and pDC were isolated and 
cultured with influenza virus to assess IFNα production.  The 180-minute exercise bout 
was expected to result in significant fatigue and mood change, and therefore these factors 
were assessed before and after exercise.  In the second set of experiments, pDCs from 
healthy subjects were co-cultured with catecholamines and cortisol, or with varying 
glucose concentrations in the presences or absence of influenza virus to determine how 
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2. Materials & Methods 
 
2.1 Research subjects and exercise conditions 
All procedures were approved by the Institutional Review Boards at Iowa State 
University (Ames, Iowa). In the first set of experiments, of the study, twenty-two subjects 
(17 male, 5 female) considered healthy and free of any condition that might alter immune 
variables of interest were recruited to participate in this study (Table 1; Supplement Fig 
1). The purpose of part 1 of the study was to determine the effects of 90 or 180 min of 
exercise on the production of IFNα by pDC. All subjects participated in a pre-test in 
which VO2max was assessed.  Based on the results of the VO2max test, ventilatory 
threshold (VT) was calculated using VE/VO2 (Fukuba et al., 1988). Blood was collected 
from all subjects pre-exercise (30 mL). Twelve subjects performed 90 min of exercise at 
85% of VT on a Monark Cycle Ergometer while the other ten subjects performed 180 
min of exercise at 85% of VT on a Monark Cycle Ergometer. During exercise, VO2 was 
measured every 20 min with a metabolic cart (Max-II, Physiodyne). Heart rate (via 
standard radio transmitters; Polar Electro Oy) and Rating of Perceived Exertion (RPE) 
(Borg, 1970) were monitored throughout the exercise with values being recorded every 
15 min. For the 180 min exercise group a fatigue scale was used to measure fatigue pre-
exercise and during exercise at 60 min, 120 min and 180 min. Subjects were allowed 
water ad libitum during the exercise. Blood was collected immediately post-exercise from 
all 22 subjects. Additionally, blood was collected 90 min post-exercise from the 90 min 
exercise group.  
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Prior to blood collection, subjects in the 180min exercise group also completed 
the following psychological surveys: Profile of Mood States (POMS) which measures 
transient, distinct mood states. The POMS consists of 65 adjectives, which are rated by 
subjects on a 5-point scale. It has been broken down into 6 factors: tension, depression, 
anger, fatigue, vigor and confusion. The Activation-Deactivation Adjective Checklist 
(ADACL) which is a multidimensional test of various transitory arousal states(Thayer, 
1967)  and the Beck Depression Inventory (BDI) which is a 21 question survey used for 
measuring severity of depression (Beck et al., 1961).  
In the second set of experiments, of the study, 14 subjects (6 male, 8 female) free 
of any condition that would interfere with any immunological outcomes were used in this 
study. Blood was collected from all 14 subjects at rest. The purpose of the second set of 
experiments was to establish the extent to which pDC IFNα production would be altered 
by epinephrine, norepinephrine, or cortisol (at a concentration similar to the expected 
blood concentration following 90 minutes of moderate exercise).  In addition, the impact 
of altered glucose concentration was evaluated.   
2.2 Blood collection and separation 
In both parts of the study, peripheral blood mononuclear cells (PBMC) were 
separated from whole blood (40ml) by Ficoll density separation. Whole blood was 
layered on Ficoll Paque Plus (Amersham Biosciences, Piscataway, NJ) and centrifuged at 
1500rpm for 20min without a brake. The buffy coat layer was removed PBMC’s were 
washed twice with AIM-V (Life Technologies) complete media and counted. 
Plasmacytoid dendritic cells (pDC’s) were separated using a BDCA micro bead kit 
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(Miltenyi) and magnetic separation (autoMACS Pro Separator) with a negative selection 
program.  
2.3 Cell culture and flow cytometry 
In the first set of experiments, pDC cells were counted and 2.5x105 pDC were 
cultured in AIM-V media with 1600 HA units of influenza A/PR/8/34 for 18 hours at 37° 
C. Additional pDC cells were placed in 0.1% BSA Stain Buffer (BD Biosciences) and 
were treated with Fc block (BD Biosciences) and refrigerated for 15min. Cells were then 
stained with Alexa 488-A goat anti-human CD303 antibody. After being placed on ice for 
30min, cells were washed with 0.1% BSA Stain Buffer. Samples were then fixed using 
BD Stabilizing Fixative (BD Biosciences) and analyzed for purity by flow cytometry (Fig 
1).  
In the second set of experiments, isolated pDC cells were counted and 1x105 pDC 
were cultured with and without 1200 HA units of influenza A/PR/8/34 virus. pDCs were 
also cultured under 6 different stimulation conditions: media control (RPMI 1640 media 
containing 1mg/ml glucose), epinephrine (Sigma) (440pg/ml), norepinephrine (Sigma) 
(1860pg/ml), cortisol (250pg/ml), a no glucose condition (0mg/ml glucose) (RPMI 1640 
no glucose; Life Technologies) and a “high” glucose condition (4mg/ml glucose) (RPMI 
1640 media containing 4mg/ml glucose). The epinephrine, norepinephrine and cortisol 
conditions used the media control media (RPMI 1640 media containing 1mg/ml glucose). 
 
 
	  	   48	  
2.4 IFNα production ELISA 
Supernatants were collected from all pDC cell cultures after 18 hours and frozen at -
80° C until all samples could be assayed together. Supernatants from all subjects were 
assayed using the VeriKine™ Human IFN-Alpha high sensitivity ELISA kit. Undiluted 
sample supernatants were added to pre coated wells and incubated at room temperature 
for 1hr. After 1hr plates were washed and then secondary antibody solution was added to 
all wells and incubated at room temperature for 1hr. After another set of washes, HRP 
solution was added to all wells and they were again allowed to incubate at room 
temperature for 1hr. After a final set of washes, TMB substrate was added and allowed to 
sit for 15min in the dark. After the 15min incubation a stop solution was added and plates 
were read at 450nm on a microtitration plate reader (Fluostar Galaxy).  
2.3 Statistical Analysis 
Statistics for all surveys, exercise data and ELISA were calculated using SPSS 
statistical software (PASW/IBM Inc.). IFNα production measured by ELISA was 
compared from pre exercise to post exercise using a one-way ANOVA (IFNα 
production). Pearson correlations were conducted to examine the role of psychosocial 
factors in IFNα response to exercise. Correlations were made between changes in IFNα 
production, fatigue scores, IL-6 production and Beck depression scores. Significance was 
assumed using p≤0.05. 
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3. Results 
 
3.1 Physiological and Psychological Measures during Exercise  
There were no significant differences between the 90 min and 180 min exercise 
groups in terms of anthropometrics, heart rate (HR), VO2 during exercise, or ratings of 
perceived exertion (RPE; Table 1).  Exercise intensity was approximately in the 
“moderate” category based on both HR (139.5±15.38 and 142.13±16.17) and RPE 
(11.2±.76 and 11.5±.63), which both increased during the exercise bouts but never 
differed significantly between groups.   Although there were no significant differences in 
fatigue scores pre-exercise between the two groups, post-exercise fatigue scores were 
significantly higher in the 180 min group versus the 90 min group (p< 0.05).  Additional 
physiological and psychological data collected from the 180 min exercise group only will 
be presented in a later section. 
 3.2 pDC purity, pDCs and IFNα 
 
Figure 1 shows the purity of the sorted pDC population.  Sorted cells were 96.8% 
pure for pDC. 
IFNα production post-exercise was significantly different between the two 
exercise groups.  For the subjects that exercised for 90 min, IFNα production by the pDC 
cells collected immediately post-exercise was significantly greater (approximately 4 
fold) than IFNα production by cells collected prior to exercise. IFNα levels returned to 
baseline 90min post exercise (Fig 2a). For the subjects that exercised for 180 min, 
	  	   50	  
production by the pDC cells collected immediately post- exercise was significantly less 
(p< 0.05) than IFNα production by cells collected prior to exercise (Fig 2b).  
3.4 Association between IFNα and other measures in the 180 min group 
 
To determine if there were associations between the primary immune outcome 
(IFNα production) and other immunological and psychological outcomes associated with 
long bouts of acute exercise; some additional measurements were taken from the 180 min 
exercise group only (ADACL, Beck, and POMS surveys and serum IL-6, all determined 
both pre- and post-exercise; Table 2).  From pre- to post-exercise, there were significant 
increases in calmness (p< 0.05), significant decreases in energy (p< 0.05), and significant 
increases in IL-6 (p< 0.05). 
Subjects with the greatest decline in IFNα after exercise showed all of the 
following: greatest level of fatigue during exercise (Fig 3) (p< 0.05), highest levels of 
RPE (p<.05), higher scores on the Beck depression scale pre exercise (p< 0.05) (Fig 4) 
and the greatest increase in IL-6 in response to exercise (p<.05). There was no significant 
correlation shown between IFNα and tension as measured by both the ADACL and 
POMS. Higher depression scores pre-exercise as measured on the Beck depression scale 
were associated with greater increases in IL-6 post-exercise (Fig 5). 
3.5 Association between neuroendocrine factors and pDC IFNα production 
 To help determine how several different neuroendocrine factors effect the 
production of IFNα by pDC, purified pDCs were cultured with epinephrine, 
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norepinephrine, and cortisol, with or without virus, and IFNα production was measured. 
pDCs which were cultured with influenza virus all had significantly greater (p< 0.01) 
IFNα production compared to the no-virus culture condition (Fig 6a).  
 Cells that were stimulated with epinephrine and norepinephrine had significantly 
greater levels of IFNα production then media control (Fig 6b). There was no statistical 
difference in IFNα between cells treated with cortisol, low glucose or high glucose 
compared to media control. Epinephrine and norepinephrine stimulated cells also had 
significantly greater levels of IFNα production compared to cortisol, low glucose and 
high glucose stimulated cells. The high glucose condition had significantly greater 
concentration of IFNα compared to the no glucose condition.  
 
4. Discussion 
An increasing number of individuals participate in long duration endurance 
activities such as running marathons or triathlons (Peters, 1997), and epidemiological 
evidence shows that an increased incidence of upper respiratory viral infection occurs 
following these events. Physical fatigue is obviously occurring during these events, but it 
is also possible that the psychological fatigue contributes to increased disease 
susceptibility as well. Recent studies have shown that prolonged exercise, such as a 
marathon or long duration triathlon, alters the body’s production of dendritic cell 
populations in the blood circulation, specifically pDCs (Nickel et al., 2012). However, 
others have shown that shorter more intense bouts of exercise may increase the numbers 
of circulating pDCs immediately after exercise (Suchanek et al., 2010). These changes in 
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pDC quantities do appear to be short-term changes, as it has been shown that pDC levels 
were not different at rest between subjects who regularly participated in moderate 
exercise and those who did not.  
90min 
The temporary exercise-induced increase in pDC production of IFNα after 90min 
of exercise may be one mechanism by which exercise improves resistance to influenza 
infection.  This effect is short-term, but may be biologically significant based on other 
findings from our lab in which we observed reduced virus in lungs of mice infected 15 
minutes after completing exercise (Sim et al., 2009).   In this study, it was also important 
to establish potential mechanisms by which exercise may alter pDC function. One 
possible mechanism is the changes in neuroendocrine factors that occur with exercise. 
Previous research has indicated that the catecholamines epinephrine and norepinephrine 
can suppress the production of IFNα by pDCs (Collado-Hidalgo et al., 2006). However, 
in the majority of these studies the levels of catecholamines used were significantly 
higher than the levels seen during 90min of moderate intensity exercise. In this study 
pDCs were stimulated with levels of catecholamines most likely to be observed during 
90min of moderate exercise (Bloomer et al., 2010; Ogawa et al., 2011; Shiiya et al., 
2011). The significant increase in IFNα production in the catecholamine-stimulated 
samples may indicate a possible mechanism by which IFNα production is increased 
during 90min of exercise.  
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180min 
The purpose of this portion of the study was to determine if 180 minutes of 
moderate intensity exercise would elicit a change in pDC function, and determine the 
extent to which various psychological factors are affected by the prolonged exercise bout. 
The results from this study suggest that prolonged exercise (3hrs) at a moderate HR 
intensity significantly suppresses IFNα production by pDC’s. We found this suppression 
to be particularly severe in individuals with the greatest levels of fatigue during exercise 
and the highest levels of perceived exertion during exercise. This could indicate that the 
suppression of pDC IFNα production results from a combination of physiological and 
psychological factors.  It is possible that the perception of fatigue contributes to immune-
suppression in addition to metabolic/energy related fatigue.  
One possibility for this decrease in IFN production after 180min of exercise could 
be a decrease in available fuel sources for the immune system, in particular pDCs. In part 
2 of the study, we saw a significant decrease in the production of IFNα by pDCs in a low 
glucose stimulated sample compared to the “high” glucose level sample. Our low glucose 
media contained no glucose, but did contain low levels of L-glutamine. It is possible that 
during long duration endurance exercise as fuel availability becomes scarce, the limited 
fuel is used by working muscle instead of being utilized by cells of the immune system. 
These results may reiterate the importance of fuel intake during long periods of exercise. 
In addition to the drop in levels of available fuel, levels of catecholamines as well as 
cortisol continue to rise throughout exercise. It could be possible that the levels of these 
hormones reach a level where they are no longer stimulating to pDCs but instead inhibit 
the production of IFNαare  
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In addition to the decrease in IFNα production, a higher level of depression before 
the exercise, as expressed on the Beck depression survey, was shown to lead to a greater 
increase in IL-6 post exercise. It is possible that subjects experiencing a higher level of 
depression (but not clinically depressed) have a more “primed” IL-6 response and the 
exercise stressor causes this greater increase as compared to non-depressed subjects. It 
should be noted that none of these subjects expressed a clinical level of depression and 
values for these more depressed subjects were on the higher level of normal. Those 
subjects who had the highest scores on the Beck depression survey pre exercise also 
showed the greatest decline in IFNα production after the 180min of exercise. Although 
we did not measure cortisol in the subjects prior to exercise, previous research has shown 
cortisol to have a depressive effect on immune function. However, we saw similar levels 
of IFNα production by pDC in media control samples compared to cortisol treated 
samples.  
These results could provide a link between the positive effects of moderate 
exercise and the negative effects of exhaustive exercise. In future studies it would be 
beneficial to determine at what time point between 90 minutes and 180 minutes does 
pDC IFNα response to virus begin to decline.. Another limitation is that subjects within 
this study did not have any clinically diagnosed psychological conditions. It would  be of 
interest in future studies to select subjects that are clinically depressed and determine 
their IFNα responses to differing durations of exercise.  
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Despite these potential limitations, these results could indicate that the decrease in 
immune function post exhaustive exercise results from both physiological and 
psychological factors, with a more prominent role played by changes to pDCs. 
	  
Figures and Tables Chapter II 
Figure 1a and b 
      
Fig 1. Flow cytometry-showing purity of pDC cell fraction after magnetic separation. 
Cells were stained with CD 303 Alexa 486-A. 1a) shows the pDC isolated cell fraction 
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Figure 2a-90min       
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Figure 2b-90min 
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Figure 2c-180min 
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Figure 2: IFNα production by pDC cells pre and post exercise. 2a-b) IFNα production by 
pDC’s measured in pg/ml at 3 time points: pre exercise, immediately post 90min of 
exercise, 90min post exercise. Fold change and absolute change in IFNα production 
compared to baseline was significantly greater (p< .01) immediately post 90min of 
exercise compared to both pre exercise and 90min post exercise. There was no difference 
between fold change or absolute change in IFNα production pre exercise compared to 
90min post exercise. 2c-d) IFNα production by viral stimulated pDC cells before and 
after 3 hours of moderate intensity exercise. Fold change and absolute change in IFNα 
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Figure 3: Change in IFNα production by pDC cells from pre to post exercise compared to 
level of fatigue at the conclusion of 3hrs of exercise. Subjects with the greatest level of 
fatigue during exercise also showed the greatest decline in IFNα production post exercise 




Figure 4: A comparison between change in IFNα production from pre to post exercise 
and score on the Beck depression inventory pre exercise. There was a significant negative 
correlation (p< .05) between score on the Beck depression inventory pre exercise and 
change in IFNα production, in that the greater the depression score, the greater the 
decline in IFNα production.  
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Figure 5 
	  
Figure 5	  Correlation between Beck depression score pre exercise and change in serum IL-
6 from pre to post exercise. There was a significant correlation (p< .05) between Beck 
depression score and change in IL-6, in that the greater the score on the Beck depression 
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Figure 6 
	  	  
Fig 6. Production of IFNα by pDCs stimulated with various neuroendocrine factors and 
different amounts of glucose. IFNα production by pDCs stimulated with influenza virus 
was significantly greater (p< 0.05) in all conditions as compared to non-virus stimulated 
controls. IFNα production by pDCs stimulated with epinephrine and norepinephrine was 
significantly greater (p< 0.05) than IFNα production by media control, cortisol, no 
glucose and high glucose treatments. IFNα production in the high glucose (4mg/ml 

























































* - Significantly greater IFNa production (p< 0.05) compared to media, cortisol, no glucose and high glucose groups
+ - Significantly greater IFNa production (p< 0.05) compared to No Glucose 








IFNa production by pDC under different stimulation conditions
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24.08±3.5 56.38±7.67 139.5±15.3 11.2±.7 1.51±0.81 6.6±1.12 
180min 
Exercise  
22.5±3.6 54.14±8.77 142.1±16.1 11.5±.6 1.71±0.84 9.57±1.42 
 
Table 1. Research subjects age and exercise characteristics. Immediate post exercise 
fatigue was the only measure that showed a significant difference between the 90min and 
180min exercise group. Subject average HR during exercise was in the moderate range 
and fell in between 60-75% of subjects’ age predicted max. Measures of RPE were 
similar between both groups and were in what is considered a moderate intensity range. 
Table 2.  











Pre Exercise 843.50±150.3 0.95±.0 17.7±.9 7.7±.53 13.5±.9 7.5±.8 2.9±.6 
Post 
Exercise 593.37±190.3 3.22±.4 18.3±1.3 13.5±.9 11.1±.8 6.9±.6 
 
Difference -250.15* 2.28* 0.6 5.8* -2.4+ -0.6  
	  
Table 2. Subject scores on measures of psychological stress as well as changes in IL-6 
before and after 180min of exercise. There were significant (p< 0.05) increases in serum 
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IL-6 and increases in subject calmness on the ADACL post 180min of exercise. There 
was also a trend (p <0.1) for a decrease in energy as measured on the ADACL. There was 
no significant difference on any measure of the POMS scale or Beck depression scale.  
 
	  
Supplemental Figure 1. A brief diagram showing the breakdown of subjects for 
Experiment 1. Twenty-four subjects were originally qualified for the study and agreed to 
participate. Two subjects in the 180min exercise group had illnesses arise on the day of 
exercise and were excluded from the study at that point. In the final count 12 subjects 
completed 90min of exercise and 10 subjects completed 180min of exercise.  
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Abstract 
Type I interferons (IFNα/β) may exhibit adjuvant activity as demonstrated in a mouse 
influenza model.  Previous findings from our laboratory showed that 90 min of exercise 
in young adults resulted in a 3-fold increase in influenza-stimulated IFN-α production by 
peripheral blood plasmacytoid dendritic cells (pDC’s). We hypothesized that 90 minutes 
of exercise immediately after vaccination would result in increased antibody response 
(possibly due to increased IFNα by pDC’s) and performed two experiments. In the first 
experiment, 14 young males and females were vaccinated with the A/California/7/09 
H1N1 vaccine and then half of the subjects exercised moderately for 90 minutes on a 
cycle ergometer whereas the remaining subjects rested. In the second experiment, 18 
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young males and females were vaccinated with the 2011-2012 seasonal influenza vaccine 
to compare the effect of exercise on a seasonal vaccine response with response to the 
“novel” 2009 vaccine.   In the second experiment, subjects were divided into three 
groups: no exercise, 45min exercise, or 90min exercise performed immediately after 
vaccination.  Blood was collected pre-immunization and at 2, and 4 weeks post-
immunization. Anti-influenza IgG and IgG1 antibody in serum was assessed by ELISA.  
In Experiment A at 2wk post, the relative increase in anti-influenza IgG compared to pre-
immunization was a 3.5 fold increase in the exercise group, and only 1.5 fold change in 
non-exercisers. Similarly at 4wk post, a 3.2 fold increase was found in the exercised 
group whereas the change in the non-exercise group was only 1.4 fold above pre-
immunization. Similar results were found in Experiment B with the greatest increase in 
antibody coming from the 90min exercise group. The findings show some promise with 
respect to moderate exercise as a vaccine “adjuvant” if performed immediately post 
vaccination. 
1. Introduction 
It has been shown that acute exhaustive exercise is associated with increased 
susceptibility to infection, particularly upper respiratory tract infections 28. According to 
the ‘J curve’ model, moderate levels of exercise are thought to be protective whereas 
intense prolonged exercise is associated with increased susceptibility to infection24. The 
mechanisms that underlie this relationship are still largely unknown.  One possibility are 
Type I interferons, one of the first lines of defense against viral infections. In our 
laboratory we have shown that moderate exercise for 90min induced a 3-fold increase in 
IFNα, by plasmacytoid dendritic cells (pDC).  
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Type I interferons can play the linking role between the innate and adaptive 
immune systems by the stimulation of dendritic cells which causes maturation and 
presentation of antigen to adaptive immune cells20, 34.  Previous studies have also 
indicated that type I interferons play a role in enhancing humoral immunity, particularly 
IgG as well as inducing isotype switching18, 19. It has been shown that type I interferons 
may have some adjuvant activity, with some research being done in an influenza model3, 
35. There is also evidence that increased IFNα may have a role in modifying the body’s 
CD4 memory response to antigen11.  
Influenza virus is a segmented RNA virus that is known for causing severe 
respiratory tract infection in humans each year. Although the entire population is at risk 
each year, the older population (>65years of age) and the younger population (<10 years 
of age) are considered more susceptible to infection than their middle-aged counterparts. 
One reason for this increased susceptibility may be decreased response to the seasonal 
influenza vaccine, which can provide less then half the protection to older adults then it 
does to younger subjects21.  Developing strategies to enhance the seasonal flu vaccine 
could help to decrease the number of severe influenza infections each year.  
In addition to the annual influenza season, there is an ever-present threat of the 
emergence of new strains of pandemic influenza A virus that leave even the younger 
adult population at risk of severe infection.  One example of this occurred in 2009, when 
the novel H1N1 (A/California/07/9) strain of influenza arose and quickly spread 
worldwide.  During the 2009 H1N1 outbreak, the younger adult population showed an 
increased number of hospitalizations and increased risk of mortality in comparison to 
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seasonal influenza strains 32. Novel strains of influenza tend to pose a greater danger to 
society, as there is rarely a vaccine ready at the time of first outbreak. In addition, since 
the virus is novel, there is very little chance of there being any population-level immune 
memory from previous infections to ward off the infection. Therefore it may be even 
more imperative that we find ways to enhance the efficacy of a vaccine to a novel 
influenza strain as how quickly we can generate a response and how potent of a response 
we generate may be the difference between sickness and health.  
Several studies have looked at using exercise as a form of influenza vaccine 
adjuvant7, 26; these studies have examined both aerobic29 as well as anaerobic type 
exercise4, 8, 9The majority of the studies that examined anaerobic exercise focused on 
eccentric type exercise prior to administration of the vaccine performed in the same limb 
that received the vaccineextremities8, 10. Several of these studies have shown an increase 
in antigen specific antibody response among exercisers compared to non-exercising 
controls, although these effects were not consistent across viral strains9, 10. At the same 
time, other studies have shown no difference between exercise groups and non exercise 
groups4. Several factors can contribute to the varying results found in these studies. 
Edwards et al. showed that varying the intensity of eccentric type exercise did not change 
the antibody response to vaccine9. And Campbell et al. showed that timing of the exercise 
prior to vaccination did not alter the immune response 4, although this study indicated 
results may have been skewed by an unusually high response among all subjects. In 
either case, there seems to be at least no negative effects to eccentric exercise prior to 
vaccination.  
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There have been very few studies that have evaluated aerobic exercise and its 
effects on vaccine response29. Neither of these studies showed major improvements in 
antibody response among the exercising group although Ranadive et al. did suggest a 
possibility that exercise may be a possible influenza vaccine adjuvant in older adult 
women29. In both studies, aerobic exercise was performed prior to receiving the vaccine 
and in both of these studies; exercise was limited to less than  60 min. No studies to our 
knowledge have looked at longer duration moderate aerobic exercise and its effects on 
response to influenza vaccine.  
Several factors may play a role in the body’s response to vaccine. Excessive stress 
has been shown to have deleterious effects on the immune system. Previous research has 
shown that individuals who are subject to stressful work environments have suppressed T 
cell function as well as decreased immune cytokine function14, 25.  Numerous studies also 
have shown a negative correlation between psychological stress and antibody response to 
vaccine 16, 27. There is also indication that diet could play an important role in the body’s 
defense against influenza infection 12 and may also have a role in the response to 
influenza vaccination 17.   Therefore, many host factors can influence vaccine 
responsiveness.  
We hypothesized that a single session of moderate intensity exercise immediately 
following immunization with the novel A/California/7/09 H1N1 vaccine or seasonal 
influenza vaccine would result in increased antibody titer at 2 and 4 weeks post 
vaccination compared to control. It was also hypothesized that subjects with lower levels 
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of stress, measured through psychological surveys, would have a greater increase in 
antibody titer.  
 
2. Methods 
2.1 Research subjects and psychological surveys 
To test the hypotheses, the study was carried out in 2 separate experiments. All 
procedures were approved by the Institutional Review Boards at Iowa State University 
(Ames, Iowa). Experiment A included fourteen subjects (age 22±3.2 yrs) and Experiment 
B included seventeen subjects (age 24.25±4.35). Individuals were excluded if they were: 
taking medications for psychological disorders or medications that altered immune 
variables (e.g., oral corticosteroids); had any medical condition known to affect immune 
outcomes including autoimmune disorders; or were unable to perform exercise safely.    
Subjects responded to questions regarding recent influenza symptoms in an effort 
to exclude individuals that may have been infected with the H1N1 (A/California/7/09) 
virus in Experiment A and the seasonal flu in Experiment B. Subjects also completed the 
following psychological surveys: Life Orientation Test (LOT)30, which can be used to 
measure optimism; the Perceived Stress Scale (PSS)6 , which is used to measure to what 
degree a person appraises a life situation as stressful; Sense of Coherence (SOC)1, used to 
assess a persons orientation and internal strengths and helps to explain successful coping 
with stressors; Positive and Negative Affect Scale (PANAS)36, measures positive and 
negative constructs as both states and traits; and Profile of Mood States (POMS) which 
measures transient, distinct mood states. The POMS consists of 65 adjectives, which are 
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rated by subjects on a 5-point scale. It has been broken down into 6 factors: tension, 
depression, anger, fatigue, vigor and confusion. A diet assessment survey 
(NurtritionQuest) was given to subjects in Part one prior to initial blood collection.  
Surveys were correlated with immune indices to determine how psychological or diet 
status may effect immune response to vaccination.  
2.2 Blood collection and vaccination 
Blood was taken from the antecubital vein (30ml) in all subjects just prior to 
immunization. In Experiment A, subjects were immunized with the inactivated 
A/California/7/09 H1N1 vaccine by intramuscular injection. In Experiment B subjects 
received the 2011 seasonal flu vaccine (A/California/7/09, A/Perth /16/2009, 
B/Brisbane/60/2008) by intramuscular injection.  
2.3 Exercise conditions 
In Experiment A subjects were randomly assigned to an exercise group (90min) 
or non-exercise group. In Experiment B subjects were randomly assigned to 1 of 3 
groups: no exercise, 45min of exercise or 90min of exercise. Exercise for both portions of 
the study was performed at 60-70% of age estimated HR max on a Monark Cycle 
Ergometer.  
Exercise subjects were allowed water ad libitum throughout the exercise. Heart 
rate (HR) and Ratings of Perceived Exertion (RPE)2 were measured every 10 min 
throughout the exercise. Non-exercise subjects remained inactive for 90 min post 
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vaccine. All subjects returned to the laboratory at 2 weeks and 4 weeks post 
immunization for blood collection.  
2.4 Serum antibody assay 
After collection, blood was allowed to clot, was centrifuged, and serum was 
frozen until subsequent measurement of anti-influenza antibodies by ELISA.  Samples 
from the same individual for all time points were run together on the same plate to 
minimize variability. Briefly, for A/California/7/09 plates were coated with 1 µg/ml HA 
peptide followed by overnight incubation. For A/Perth /16/2009 in Experiment B, plates 
were coated with 256 HA units/ml, followed by an overnight incubation. (Influenza B 
was not measured, as influenza B virus was not available to our lab at the time of this 
experiment.) Plates were washed 3-5 times with PBS/0.05% Tween 20 between each 
step. Dilutions of serum (1:200) were added to the wells in duplicate. (This dilution was 
chosen after preliminary trials determined this to be ideal; data not shown.)  After 
incubation, AP-conjugated goat anti-human IgG and IgG1 were added (at 1:100 dilution 
for IgG and 1:10 for IgG1). Finally phosphatase substrate (Sigma) was added and optical 
density was assessed at 405 nm at 10, 30 and 50min on a Fluostar plate reader. The 
response was calculated as the fold change in antibody from 2 or 4 weeks post 
vaccination to baseline measures.  
2.5 Statistical analysis 
Statistics for all surveys, exercise data and ELISA were calculated using SPSS 
statistical software (PASW/IBM Inc.) and using ANOVA as well as repeated measures. 
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A mixed ANOVA was used to compare serum anti-influenza immunoglobulins (IgG an 
IgG1) to the different exercise durations post vaccination.  Correlations using Pearson 
correlations were used to compare psychological survey outcomes and immune 
parameters. All data are reported as mean ± standard error of the mean (SEM). Values of 
p< 0.05 were considered statistically significant, while values of 0.05 <p< 0.1 were 
considered a trend.  
 
3. Results 
There were no significant differences between exercise and non-exercise subjects 
in terms of anthropometrics or resting HR in Experiment A (Table 1a). Exercise intensity 
for subjects exercising for 90min in Experiment A was in the “moderate” category based 
on RPE (12.29±.56) as well as HR (136.7±6.98 bpm). In Experiment B, there was no 
significant difference between the no exercise, 45min exercise or 90min exercise groups 
in terms of age or resting HR. There was also no significant difference between the 
45min and 90min exercise groups in terms of exercise HR (143.32 ±7.91 and 141.75 
±9.32) or RPE (11.62 ±2.22 and 12.45 ±1.76), which both increased during exercise but 
never differed significantly between groups (Table 1b).  
Findings from Experiment A with subjects receiving the novel H1N1 
A/California/7/09 vaccine showed that exercise increased antibody responses (Fig 1). 
Subjects who exercised for 90 min immediately post vaccination showed a significant 
increase in anti influenza IgG antibody titer at 2weeks (p< 0.05) and 4 weeks (p< 0.05) 
post vaccination. There was no statistical difference within groups at 2 and 4 weeks post 
vaccination. Subjects who exercised for 90 min also had a significantly greater increase 
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in the anti-influenza IgG1 antibody subclass at 2 weeks (p< 0.05) and 4weeks (p< 0.05) 
post vaccination. There was no difference within groups from 2weeks to 4 weeks post 
vaccination. Values are reported as a ratio comparing 2 weeks and 4weeks post to pre 
immunization values.  
 In Experiment B in which subjects received the 2011-2012 seasonal influenza 
vaccine, the exercise effect varied somewhat by strain of influenza and antibody 
class/subclass measured.	  H3N2 A/Perth /16/2009 influenza specific IgG was not 
significantly different between any of the 3 three groups. However there was a trend 
between the 90 min and 45 min exercise groups in that those exercising for 90 min had a 
greater increase in antibody titer at 2 and 4 weeks post vaccination compared to 45 min 
exercise group (Fig 2a).  H1N1 A/California/7/09 influenza specific IgG was 
significantly greater in the 90 min exercise group compared to both the non-exercise 
group as well as the 45 min exercise group at 4 weeks post vaccination. At 2 weeks post 
vaccination there was a significant difference between the 90min group and the 45min 
group (Fig 2b). H3N2 A/Perth/16/2009 influenza specific IgG1 antibody ratio was 
significantly greater in the 90 min exercise group compared to the 45 min exercise group 
(p< 0.05) at both 2 weeks and 4 weeks post vaccination. There was also a trend at 4 
weeks post vaccination that the 90min exercise group’s change in IgG1 antibody ratio 
was greater than the non-exercise group (p< 0.1) (Fig 2c).  H1N1 A/California/7/09 
influenza specific IgG1 fold change in antibody was significantly greater at both 2 and 4 
weeks post vaccination for the 90 min exercise group compared to the 45 min exercise 
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group. There was also a trend at both 2 and 4 weeks such that 90 min exercise group had 
a greater fold change in antibody than no exercise (p< 0.1) (Fig 2d). 
 In Experiment A, subjects were asked to complete a number of psychological 
surveys prior to receiving the novel H1N1 vaccine. There was a significant negative 
correlation (p< 0.05) between IgG1 antibody production at both 2 and 4 weeks and score 
on the PSS (Table 2). There was also a negative correlation trend (p< 0.1) at 4 weeks 
between IgG production and scores on the PSS and POMS anger (Table 2).  
 In Experiment B, the only psychological measure that was found to be 
significantly correlated with antibody response was in relation to the PANAS 
measurement. There was a significant negative correlation between fold change in 
antibody (H3N2 IgG, H3N2 IgG1 and H1N1 IgG1 at 2 weeks and H3N2 IgG at 4 weeks) 
and the negative affect score on the PANAS (p<.05; Table 2). There was also a 
significant negative correlation between fold change in antibody (H1N1 IgG, H1N1 
IgG1and H3N2 IgG1 at 4 weeks) and the negative affect score on the PANAS (p<.01) 
such that the greater the score on the negative affect portion of the PANAS correlated 
with the smaller the increase in antibody titer at 2 weeks post vaccination. There was also 
a significant positive correlation between the H1N1 IgG and H1N1 IgG1 fold changes at 
4 weeks and the positive affect score on the PANAS scale (p< 0.05) such that the greater 
score on the positive portion of the PANAS was positively correlated with the greater 
increase in antibody titer. There was no significant difference between the 3 exercise 
groups on any measure on the psychological surveys. 
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 There were no significant differences found among subjects in any groups based 
on any aspect of the Nutrition Quest diet survey. There were also no significant 
correlations between any measure on the diet survey and antibody responses to the 
influenza vaccinations in either Experiment A or Experiment B.  
4. Discussion 
These findings suggest that exercise may have some “adjuvant-like” effects with 
respect to influenza vaccination in young adults, as suggested by other groups7, 26. These 
reviews point to the potential of using exercise to enhance immune responses to vaccine. 
The large percentage of these studies use exercise as a pre vaccine strategy, where our 
study used exercise post vaccine. Although using exercise after vaccine is not entirely 
novel, this is one of the only studies to use moderate intensity aerobic exercise 
immediately post vaccine focusing on a muscle group where the vaccine was not 
administered.  
The positive effects of 90 minutes of exercise immediately following vaccine 
were seen over multiple years and in response to both a novel influenza vaccine as well 
as the more common seasonal influenza vaccine. While the exact mechanisms by which 
this increase occurred are unclear, it may be due in part to the increased IFNα production 
by pDCs that we observed with the same type of exercise. The same benefit was not seen 
when subjects exercised for only 45 min. Although the amount of IFNα production by 
pDC after 45min of exercise has not been studied in our lab, it is possible that there is not 
the same increase in IFNα after only 45 min of exercise as was seen after 90 min of 
exercise.  In addition, the immediate post-exercise increase in IFNα after 90 min of 
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exercise was no longer present 90 minutes after completion of the exercise; because of 
this it is possible that a short-term change in IFNα due to exercise leads to a long term 
effect 2 and 4 weeks later with respect to antibody titer. 
Interestingly we saw no difference between antibody titers at 2 weeks and 4 
weeks in any of the groups or for any virus subtypes. The reason for this is not clear, as it 
was the same among exercisers and non-exercisers. One possibility is that antibody 
production in healthy young adults reaches peak levels more quickly (~ 2 weeks) as 
compared to middle aged or older adults.  
The current study also added further evidence that psychological state at the time 
of vaccination may play a role in the subsequent immune response. In Experiment A we 
saw a negative correlation between influenza specific antibody and subjects’ responses 
on the PSS. This indicates that those subjects who had the greatest degree of perceived 
stress at the time of vaccination had the smallest antibody response to the novel influenza 
vaccine. Similar outcomes were seen in Experiment B. Subjects who had the greatest 
negative scores on the PANAS also had the smallest increases in antibody response to the 
seasonal influenza vaccine. Subjects who reported the highest scores on the positive 
portion of the PANAS also had the greatest increases in influenza specific antibody, 
suggesting that that a positive outlook on life could lead to an increase in antibody 
responses to vaccination. This is similar to results found in subjects receiving the 
hepatitis vaccine. Subjects who showed the greatest levels of positive affect also had the 
greatest antibody responses23, while those exhibiting the greatest negative affect had the 
greatest decline in antibody response 22.  Other researchers have examined the role of 
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mood in vaccine responsiveness and/or influenza susceptibility, but most studies focused 
on elderly populations (who more frequently experience loneliness or depression than 
younger adults); thus, although the results may not be directly comparable to this study’s 
considering the age differences, it is interesting to note that poor psychological states 
were also related to poor immune outcomes in previous research13, 31. 
Diet was not a factor in vaccine responsiveness.  Other teams have explored the 
relationship between diet and vaccine response previously.  For example, it has been 
shown that Vitamin A deficiency can lead to a disruption of antibody production in 
response to vaccine33. Research also points to a potential change in immune response to 
influenza vaccination based on intake of dietary fatty acids15.  Some other studies focused 
on the effects of energy restriction on immune response to influenza infection. The 
majority of these studies showed a decline in immune response when virally challenged5, 
12. Using a relatively healthy population of subjects, we saw little in the way of dietary 
deficiencies or overuse. Our subjects were consuming normal diets and not under any 
dietary restrictions or deficiencies, so their sufficient diets may explain the lack of any 
observed differences.  
Despite the potentially positive findings within this study, there are still potential 
limitations to this work. First of all, the population used was young and relatively 
healthy, while those most likely to experience greater severity of influenza infection  are 
the infant and older populations. It is important to see if this type of intervention prior to 
vaccination is beneficial to these at risk populations. A second limitation is the type of 
exercise used. This study used only cycling as an intervention. It is possible that other 
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types of aerobic exercise could be just as beneficial or potentially of greater effect. 
Exercise that involves the entire body, like running, may elicit a greater response than 
cycling, which uses primarily the lower limbs.  
Future experiments will be necessary to determine whether pDC IFNα production 
is the mechanism by which exercise improves antibody response. Also, it will be 
important to identify the cellular pathways affected by exercise that result in altered IFNα 
production, and determine how exercise alters these pathways.  
 












Exercise 23.67 ±3.86 77.81 ±4.31 136.7 ±6.98 12.29 ±.56 
Control 22.42 ±4.84 74.67 ±5.67 










Exercise 25.14 ±3.12 68.43 ±5.67 
  45min 
Exercise 24.76 ±2.65 66.11 ±6.98 143.32 ±7.91 11.62 ±2.22 
90min 
Exercise  23.45 ±3.87 64.75 ±7.16 141.75 ±9.32 12.45 ±1.76 
 
Table 1. A comparison of basic anthropometric data and measurements taken during 
exercise in all groups from Experiment A (Table 1a) and Experiment B (Table 1b). The 
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following values are included: average age of subjects, resting heart rate taken just prior 
to vaccination after subjects had been seated for 5minutes, average exercise heart rate 
during exercise which was taken every 10 minutes throughout exercise, and average 
rating of perceived exertion (RPE) taken every 10 minutes throughout exercise. There 
were no significant differences among exercise subjects and non-exercise subjects.  
 
Table 2 
 Virus   Time 
Perceived Stress Scale 
(Pearson Correlation)  
POMS Anger 
(Pearson Correlation) 
H1N1 IgG 2 weeks     -.366       -.425       p<.1 
  4 weeks      -.449     p<.1      -.436       p<.1 
H1N1 IgG1 2 weeks     -.751     p<.05       
  4 weeks     -.606     p<.05       
 
Table 2. Correlations between antibody titers and scores on the (PSS) and the POMS 
Anger portion given just prior to receiving the novel H1N1 influenza vaccine. There were 
significant negative correlations (p< 0.05) between the H1N1 IgG1 antibody titer at both 
2 weeks and 4 weeks post vaccination and scores on the PSS. There was a trend for a 
negative correlation (p< 0.1) at 4 weeks between the IgG antibody titer and score on the 
PSS. There was also a trend for a negative correlation (p< 0.1) between IgG antibody at 
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Table 3 
 Virus   Time 
PANAS Negative Score 
(Pearson Correlation)  
PANAS Positive Score 
(Pearson Correlation) 
H1N1 IgG 2 weeks     -.498        .344 
  4 weeks      -.641     p<.01      .532        p<.05 
H1N1 IgG1 2 weeks     -.510     p<.05      .482 
  4 weeks     -.630     p<.01      .511        p<.05 
H3N2 IgG 2 weeks     -.522     p<.01      .197 
  4 weeks     -.598     p<.05      .297 
H3N2 IgG1 2 weeks     -.585     p<.05      .453 
  4 weeks     -.645     p<.01      .341 
 
Table 3. Correlations between antibody titers and subjects’ answers to PANAS items 
prior to seasonal influenza vaccination and exercise. This table includes Pearson 
Correlations listed first followed by the level of significance if one was observed There 
were significant negative correlations (p< 0.05) between all viruses at all time points 
(excepting H1N1 IgG) and negative score on the PANAS. There was a positive 
correlation (p< 0.05) between the H1N1 IgG and H1N1 IgG1 at 4 weeks and positive 
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Figure 1b-2009 Vaccine 



















2 weeks 4 weeks
*
+
*- 90min exercise is significantly greater (p<.05) then no exercise
+-90min exercise trends greater (p<.08) then no exercise  
 
Fig 1: A single bout of moderate exercise increases both anti influenza IgG and IgG1 
antibody titer in response to influenza vaccine. Subjects were given the novel 
A/California/7/09 vaccine intramuscularly. Values are reported as a ratio comparing 2 
weeks and 4weeks post to pre immunization values.  1a) Subjects who exercised for 
90min immediately post vaccination showed a significant increase in anti influenza IgG 
antibody titer at 2weeks (p< 0.05) and 4 weeks (p< 0.05) post vaccination. There was no 
statistical difference within groups at 2 and 4 weeks post vaccination. 1b) Subjects who 
exercised for 90min had a significantly greater increase (p< 0.05) in anti influenza IgG1 
at 2 weeks and 4weeks post vaccination. There was no difference within groups from 
2weeks to 4 weeks post vaccination. 
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Figure 2a- 2011 Vaccine 
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90min Exercise  
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* - p <.05 for 90min exercise compared to 45min exercise
**- p <.05 for 90min exercise compared to no exercise and 45min exercise
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* - p <.05 for 90min exercise compared to 45min exercise
+ - p<.08 for 90min exercise compared to no exercise
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90min Exercise  
*+
*+
* - p <.05 for 90min exercise compared to 45min exercise
+ - p<.08 for 90min exercise compared to no exercise
2 weeks 4 weeks
 
 
Figure 2: A single bout of 90min of moderate exercise increases both anti influenza IgG 
and IgG1 antibody titer in response to seasonal influenza vaccine. Subjects were given 
the 2011-2012 seasonal influenza vaccine intramuscularly. Values are reported as a ratio 
comparing 2 weeks and 4weeks post to pre immunization values.  2a) H3N2 A/Perth 
/16/2009 influenza specific IgG was not significantly different between any of the 3 three 
groups. However there was a trend (p< 0.1) between the 90min and 45min exercise 
groups in that those exercising for 90min had a greater increase in antibody titer at 2 and 
4 weeks post vaccination compared to the 45min exercise group. 2b) H1N1 
A/California/7/09 influenza specific IgG was significantly greater (p< 0.05) in the 90min 
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exercise group compared to both the non exercise group as well as the 45min exercise 
group at 4 weeks post vaccination. At 2 weeks post vaccination there was a significant 
difference (p< 0.05) between the 90min group and the 45min group.  2c) H3N2 
A/Perth/16/2009 influenza specific IgG1 antibody ratio was significantly greater (p< 
0.05) in the 90min exercise group compared to the 45min exercise group (p< 0.05) at 
both 2weeks and 4 weeks post vaccination. There was also a trend at 4 weeks post 
vaccination that the 90min exercise group ratio was greater than the no exercise group 
(p< 0.1). 2d) H1N1 A/California/7/09 influenza specific IgG1 antibody ratio was 
significantly greater (p< 0.05) at both 2 and 4 weeks post vaccination for the 90min 
exercise group compared to the 45min exercise group. There was also a trend at both 2 
and 4 weeks such that 90min exercise group had a greater antibody ratio than the no 
exercise group (p< 0.1). 
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Influenza vaccines containing interferon-α (IFNα) have been shown to increase 
antigen-specific antibody titer in mice. Previous findings from our lab demonstrated that 
90 min of moderate intensity exercise in young adults increased influenza-stimulated 
IFNα production by plasmacytoid dendritic cells, whereas 180 min of exercise decreased 
IFNα production. We have also found that 90 min of moderate intensity exercise 
immediately following H1N1 vaccination increased serum anti-influenza IgG at 2 and 4 
weeks post-immunization. To examine the possibility that exercise could work as a 
vaccine adjuvant, we developed a mouse model to examine antibody response and 
specific cellular immune alterations. In these experiments, 39 male BALB/c mice were 
vaccinated with 50µL of inactivated A/PR/34 influenza (intramuscular route). 
Immediately following vaccination, mice were separated into 4 groups: no exercise, 45 
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min of exercise, 90 min of exercise, and 180 min of exercise. Blood was collected at 2 
weeks post immunization, and blood and spleens were collected at 4 weeks post 
immunization. Anti-influenza IgG, IgG1 and IgG2a antibodies in serum were assessed by 
ELISA. The results showed a significant increase in anti-influenza IgG, IgG2a in 90 min 
exercise mice compared to non-exercise mice. However, anti-influenza IgG, IgG1 or 
IgG2a levels were not different in non-exercise mice compared to either the 45 min or 
180 min exercise groups. The results also showed a significant increase in the number of 
antigen specific CD8+ T cells in the spleen, in the 45 min and 90 min exercise treatment 
compared to non-exercise mice. These results support previous work in our lab and 
indicate a benefit of 90 minutes of moderate exercise immediately following influenza 
vaccination. The findings suggest that 45 minutes of moderate exercise may be 
insufficient to elicit a stronger antibody response whereas 180 minutes may not be 
optimal to elicit a significantly greater antibody response to vaccination.  





Seasonal influenza virus is a highly contagious upper respiratory tract infection 
that can lead to widespread morbidity and mortality each year 9, 25.  After exposure to 
influenza, virus can be detected in the upper respiratory tract within hours. Immune 
responses are activated quickly after infection and include production of chemokines and 
cytokines. One of the cytokines seen during this initial immune influx are the type 1 
interferons 30, 33.  Type I interferon induces an antiviral state but also contributes 
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immunomodulatory effects that can enhance immune defense against viral infection 
and/or may potentiate vaccine effectiveness..   
One of the type I interferons, interferon alpha (IFNα) is an immunomodulating 
protein that is induced by TLR and RIG-I pathways in response to viral infections like 
influenza8, 28, 36. IFNα serves an antiviral function by activating signaling pathways within 
other immune cells that stimulate the production of antiviral proteins24 and these proteins 
are known to work by interfering with viral replication3, 29. The type I interferons have 
been indicated as one of the many possible links between the innate and adaptive immune 
systems by their ability to stimulate dendritic cells which in turn causes maturation and 
presentation of antigen to cells of the adaptive immune system22, 34.  
It has been shown that type I interferons may have some adjuvant activity, with 
some research being done in an influenza model4, 35. Other studies have indicated that 
interferons, like IFNα, are important for increasing the body’s antibody response to 
influenza vaccination 32. Studies have also indicated that IFNα may play a role in 
enhancing the body’s humoral immune response, particularly IgG as well as inducing 
isotype switching in B cells3, 10, 12, 15, 20, 21.  A relatively recent vaccine trial tested 
administering IFNα sublingually just prior to influenza vaccination.  However, this 
treatment failed to elicit any enhancement of the primary antibody response to 
vaccination 19.  Another study done in 2007 in mice, indicated increased protection 
against lethal influenza infection when mice were given type-I interferon prior to 
infection1.  Looking primarily at these studies, the results seem inconclusive. But in either 
case, the administration of IFNα did not hinder the effectiveness of the vaccine.  
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IFNα has been shown to promote CD8 T cell expansion by serving as a third 
signal, along with antigen and costimulation, to induce a productive response5, 6. It has 
also been shown that IFNα is cirtical not only in CD8 T cell expansion but also is critical 
to the development of CD8 memory cells18. It is important to note that these studies were 
carried out with live influenza infection and not in response to inactivated virus vaccine. 
It may be important for induction of IFNα through alternative mechanisms (i.e. exercise) 
to elicit these same CD8 cell responses when inactivated virus is used. One of these anti 
viral products produced by T cells in response to viral stimulation is granzyme B. 
Granzyme B works by entering an infected cell and inducing apoptosis2. Up regulation of 
granzyme B occurs during an immune response to infection or in response to vaccination, 
and certain vaccine adjuvants have been shown to increase its production23. The 
production of granzyme B occurs only after the T cells have recieved a third signal from 
cytokines such as  IFNα. There is also evidence that increased IFNα may play a role in 
the regulation of antiviral products including IFN-γ produced by T cells31. Some evidence 
suggests that IFNα may increase the production of IFN-γ by T cells in response to viral 
infection, while it can have limiting effects on IFN-γ’s ability to induce NO production in 
macrophages7.  
Epidemiological studies suggest that moderate exercise is associated with 
improved resistance to infection 26, and we have also found that a single session of 
moderate exercise prior to infection reduces the lung influenza viral titer in mice. 
Conversely, it has also been shown that acute exhaustive exercise is associated with 
increased susceptibility to infection, particularly upper respiratory tract infections, like 
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influenza 27. The mechanisms that underlie these findings are not completely known.  
One potential mechanism for these exercise associations is type I interferon. We have 
found that moderate exercise for 90 min induced a 3-fold increase in IFNα production by 
plasmacytoid dendritic cells in response to influenza A H1N1 virus.  Also, we have 
shown in humans that 90 min of moderate intensity exercise immediately following 
H1N1 vaccination increased serum anti-influenza IgG at 2 and 4 weeks post-
immunization.  
The purpose of this study was to determine how varying lengths of moderate 
intensity exercise immediately after influenza vaccination affect the body’s immune 
response, by examining anti influenza antibody production as well as changes to the T 
cell profile in 4 different groups of exercising mice 4 weeks after vaccination.  
Given our previous data demonstrating an increase in IFNα by pDC’s in response 
to 90 min of moderate exercise, we hypothesized that a single session of moderate 
intensity exercise for 0, 45, 90 or 180 min immediately following immunization with 
vaccine would result in an increase in influenza specific antibody titer at 2 and 4 weeks 
post vaccination for the 45 and 90 min exercise groups.  We hypothesized the increase in 
antibody would be lost in the 180 min exercise group due to studies showing decreased 
immune function after long duration exercise bouts. We also hypothesized that the same 
period of exercise would increase the number of antigen specific T cells as well as 
increase the production of anti influenza cytokines and proteases such as IFNλ and 
granzyme B by CD8 T cells.   
 
 




To test the hypotheses that moderate exercise immediately after receiving an 
influenza vaccine would increase antibody titer and that exercise would increase the 
number of antigen specific T cells and T cell anti influenza products, forty-nine 10-week-
old male BALB/c mice (Charles River Labs) were used in this study. All studies were 
performed according to Institutional Animal Care and Use Committee guidelines at Iowa 





Thirty-nine mice received 50µl of inactivated A/PR/8/34 virus (512 HA units) 
intramuscularly into the quadriceps. Ten mice were not vaccinated and used as control. 
Virus was inactivated by binary ethylenimine (BEI) 17.  Briefly, a 100mM solution of BEI 
was cyclized for 75min at 36°C. The BEI was then added to pre warmed A/PR/8/34 virus 
fluid to bring the final BEI concentration to 5mM. This solution was mixed for 56hrs at 
36°C. After this incubation, 1M sodium thiosulfate was added to the virus mixture to 
reach a concentration of 20mM sodium thiosulfate. This was mixed for 60min at 20°C. 
Finally, virus was tested for inactivation by inoculating MDCK cell monolayers with 
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2.3 Exercise conditions 
 
 Immediately following vaccination, mice exercised for 0 (n=9), 45(n=10), 
90(n=10) or 180min (n=10). Exercise was performed on a treadmill at a speed of 
15m/min, which has been shown to be moderate intensity 11, 16. Non-exercising mice were 
placed in housing cages affixed to the top of the treadmill to mimic the treadmill 
environment as closely as possible. Mice were acclimated to the treadmill environment 
on 2 occasions prior to the study, both occurring no more than 24hrs before the study to 
ensure no training effect.  
 




 Blood was collected from all mice prior to, 2 weeks post and 4 weeks post 
vaccination via the saphenous vein at pre and 2 week time points and by cardiac puncture 
at 4 weeks post13. Blood was allowed to clot and centrifuged at 3500 g for 15 min, then 
serum was collected and frozen at -80°C until subsequent measurement of IgG, IgG1 and 
IgG2a anti-influenza antibodies by ELISA. Briefly, plates were coated overnight at 4 °C 
with influenza virus A/PR/8/34 diluted in carbonate coating buffer (pH 9.6) at a 
concentration of 200 HAU/ml for anti-influenza-IgG, IgG1, and IgG2a. The wells were 
blocked with 0.1% BSA solution at 37°C for one hour. Plates were washed three times 
with PBS/0.05% Tween 20 between each step. Dilutions of serum (1:50 for IgG and 1:5 
for IgG1) were added to the wells and incubated for 3 hours at 37°C. These dilutions 
were chosen after preliminary trials determined this to be ideal (data not shown).  After 
incubation, AP-conjugated rat anti-mouse IgG and IgG1 were added (at 1:100 dilution for 
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IgG and 1:10 for IgG1 and IgG2a), then incubated overnight at 4°C. Finally phosphatase 
substrate (4-Nitrophenyl phosphate disodium salt hexahydrate) (Sigma) was added and 
optical density was assessed at 405 nm at 10, 30 and 50 min using a Fluostar plate reader.  
 
2.4b Spleens 
 Spleens were collected at 4 weeks post-vaccination from all mice except 3hr 
exercisers and held in cold cRPMI (Gibco Invitrogen) until they could be homogenized 
by stomacher followed by pressing them through a 20µm cell strainer in a petri dish using 
a plunger from a 3mL syringe.  The strainer and petri dish were washed with cRPMI and 
cells were collected and filtered by centrifugation at 1500rpm in the bottom of a 15ml 
polypropylene tube. Ammonium-Chloride-Potassium ACK was added to the cells slowly 
and allowed to sit for 5 minutes followed by another wash in cold cRPMI and subsequent 
centrifugation. Spleen cells were resuspended in 0.1% BSA Stain Buffer (BD 
Biosciences) and counted using a Coulter Particle Counter.   Cells were treated with Fc 
block (BD Biosciences) and separated into 2 separate groups. One group was stained 
using the following antibodies: Alexa Fluor 700 rat anti-mouse CD44, PerCP-Cy 5.5 rat 
anti-mouse CD62, FITC rat anti-mouse CD8b and PE-Cy 7 rat anti-mouse CD11a. These 
were chosen to identify the following: CD8+ T cells (CD8b), antigen-experienced CD8+ 
cells (CD8+/CD11a+/CD8αlow ) and central memory CD8+ cells (CD8+/CD44+/CD62lo). 
The second group was stained using the following antibodies: Alexa Fluor 700 rat anti-
mouse CD44, PerCP-Cy 5.5 rat anti-mouse CD62, FITC rat anti-mouse CD4 and PE-Cy 
7 rat anti-mouse CD11a.  These were chosen to measure the following: CD4+ T cells 
(CD4), antigen-experienced CD4+ T cells (CD4+/CD11a+) and central memory CD4+ T 
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cells (CD4+/CD44+/CD62lo). After initial staining, cells were left at 4°C for 30min. All 
cells were fixed and permeabilized then group 1 was stained with APC rat anti-mouse 
IFNγ and PE rat anti-mouse granzyme B, while group 2 was stained with APC rat anti-
mouse IL2. Samples were fixed using BD Stabilizing Fixative (BD Biosciences) and 
analyzed by flow cytometry.  Cell type determination and gating was carried out using 
FlowJo 7.6 software (Tree Star).  
 
2.5 Statistical analysis 
 SPSS statistical software was used to analyze all results. A mixed ANOVA was 
used to compare serum anti-influenza immunoglobulins (IgG, IgG1, and IgG2a) and 
spleen cell populations to each of the different exercise durations post vaccination.  All 
data are reported as mean ± standard error of the mean (SEM). Values of p< 0.05 were 




3.1 Antibody responses 
 Anti-influenza IgG antibodies in serum were significantly increased (p< 0.05) in 
mice exercising for 90 min compared to non-exercise mice at 4 weeks post vaccination 
(Fig 1a). There was a trend (p< 0.1) of greater levels of IgG antibody in both the 45min 
and 180min of exercise groups compared to the no exercise group at 4 weeks post 
vaccination. There were no significant differences between any of the vaccination groups 
with respect to anti-influenza IgG at 2 weeks post-vaccination. As expected, there was a 
significant difference (p< 0.01) between all vaccinated groups and non-vaccinated group 
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at all time points such that there was a significantly greater level of IgG antibody in 
response to vaccination (results not shown).  
Anti-influenza IgG1 antibodies from serum were significantly increased at 4 
weeks post infection in the 90 min exercise group compared to the 3hr exercise group (p< 
0.05); they also trended to be greater in mice that exercised for 90 min compared to no 
exercise when measured 4 weeks post-immunization (p<0.1; Fig 1b). However, 45 or 180 
min exercise groups were not different from the non-exercise group. Anti-influenza IgG1 
was not different between exercise groups at 2 weeks post vaccination. There was a 
significant difference (p< .01) between mice, which were vaccinated, and those who were 
not vaccinated in relation to IgG1 production at 2 weeks and 4 weeks post vaccination 
(data not shown). 
Anti-influenza IgG2a antibodies from serum were significantly increased at 4 
weeks post infection in the 90 min exercise group compared to the no exercise group (p< 
0.05; Fig 1c). There was also a trend for greater antibody increase at 4 weeks post 
vaccination for 90 min exercise group compared to 45min and 180min exercise groups 
(p< 0.1). There was no difference between any groups at 2 weeks post vaccination for 
IgG2a. There was also a significant increase (p< 0.05) in IgG, IgG1 and IgG2a antibody 
at 4 weeks compared to 2 weeks for all groups.  
 
 
3.2 Spleen cell typing 
 
Spleen cells were taken to analyze lymphocyte changes that may occur in 
response to varying amounts of exercise immediately post vaccination. Total numbers of 
CD8 cells (CD8+), antigen-experienced CD8+ cells (CD8+/CD11a+) and central memory 
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CD8+ cells (CD8+/CD44+/CD62lo) were significantly higher at 4 weeks post vaccination 
in both 45min and 90min exercise compared to no exercise (Fig 2a). There was no 
difference between the 45 min and 90 min exercise group.  
 The percentage of total CD8+ cells that were antigen-experienced was 
significantly higher (p< 0.05) in both the 45 min and 90 min exercise groups compared to 
no exercise group (Fig 2b). The percentage of central memory CD8+ cells was 
significantly greater (p< 0.05) in the 45 min and 90 min groups compared to the no 
exercise group. There was a significantly greater percentage (p< 0.05) of naïve CD8+ in 
the non-exercise group compared to 45 min and 90 min exercise groups (Fig 2b). 
The influenza vaccine induced production of IFN-γ by CD8+ cells was also 
evaluated in spleen tissue for both exercised and non-exercised mice at 4 weeks post 
vaccination. The mean fluorescence intensity of IFN-γ was significantly higher (p< 0.05) 
in the 45 min and 90 min exercise groups compared to the uninfected as well as no 
exercise groups (Fig 2c). There was also a significantly higher MFI for all vaccine groups 
compared to the unvaccinated group (p< 0.05) (Fig 2c). Meanwhile, granzyme B 
production by CD8+ T cells from the spleens was also analyzed by flow cytometry. 
Results showed a significantly greater MFI of granzyme B in the 45 min and 90 min 
exercise mice compared to non-exercise mice (p< 0.05; Fig 2c).  
In addition to measuring CD8 T cell populations, CD4 T cell populations were 
also analyzed by flow cytometry. Total numbers of CD4 cells (CD4+), antigen-
experiencedCD4+ cells (CD4+/CD11a+) and central memory CD4+ cells 
(CD4+/CD44+/CD62lo) were significantly lower at 4 weeks post vaccination in the 90 min 
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exercise group compared to the 45min exercise group (Fig 3a). There was also a 
significant difference in total CD4+ cells and naïve CD4+ cells between 90 min exercise 
group and no exercise group (p< 0.05).  
The percentage of total CD4+ cells that were antigen experienced was 
significantly higher (p< 0.05) in the 45 min exercise group compared to no exercise (Fig 
3b). There was also a trend of a greater percentage of antigen experienced CD4+ cells 
from the 90 min exercise group compared to the no exercise group. The percentage of 
central memory CD4+ cells was no different among any of the groups. There was a 
significantly greater percentage (p< 0.05) of naïve CD4+ in the non-exercise group 




The results of this study further indicate that exercise may have some adjuvant 
like effects with respect to influenza vaccination in mice, similar to a previous finding in 
humans (Chapter III). It is possible that the increase in antibody titer due to exercise may 
be related to an increased IFNα production by pDC’s that we observed with the same 
type of exercise in humans.  It could also be related to increases in blood flow and 
capillary permeability caused by exercise altering circulation in such a way that greater 
amounts of antigen reach the draining lymph nodes, although the mechanisms of vaccine 
movement were not measured in this study.  
Results from influenza specific antibody ELISA testing showed significantly 
greater anti influenza IgG and IgG2a antibodies in the 90 min exercise group compared to 
no exercise. Findings also showed a significant increase in IgG1 antibodies in the 90 min 
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exercise group compared to 180 min of exercise. There was also a trend for greater 
production of IgG and IgG2a antibodies compared to baseline in the 90 min exercise 
group compared to both the 45 min and the 180 min groups. These results are similar to 
the results we saw in young adults in response to both novel influenza vaccine as well as 
seasonal vaccine. This study adds to those previous findings, by showing that the greatest 
benefit is seen at 90 min of exercise as opposed to the shorter 45min bout or greater 
180min bout of exercise. It is possible that the increase in IgG and IgG2a seen in the 90 
min exercise was not seen in the IgG1 group due to an increase in antibody class 
switching caused by increased production of IFNα17,22. 
Unlike the results that we saw in our previous human subjects, there was no 
difference between any of the vaccine groups at 2 weeks post vaccination. It was only 
after 4 weeks that differences among the groups became apparent. In our human research, 
subjects showed large increases in antibody at 2 weeks post exercise, but little increase in 
antibody titer from 2 weeks to 4 weeks post vaccination. The reason behind this is 
unknown to us at this time, but may be related to the fact our human subjects were at 
least moderately fit prior to vaccination, while the mice had no exercise training prior to 
the vaccination and subsequent acute exercise bout. Even if it was minimal and below 
recommended doses, by participating in at least some level of exercise the human 
subjects were potentially stressing their bodies enough to elicit some immune response 
which more readily primed their immune systems for action. There is research to show 
that certain activities like exercise can elicit a stress response which in turn induces these 
so called “danger signals” which can work to trigger an innate immune response14. It is 
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possible that our human subjects had enough innate immune priming by these danger 
signals to elicit a faster immune response to vaccination.    
There is a possibility that IFNα-induced activation of cellular signaling pathways 
may occur during and after the exercise period, resulting in downstream activation of 
antigen presenting cells, B cells, CD4+ and/or CD8+ T cells.  It has been shown that IFNα 
promotes antibody class switching and prolongs CD8+ effector survival. However, further 
studies are needed to clarify whether IFNα is the primary mechanism mediating this 
effect during exercise. The results from this study showed that the percentage of total 
CD8+ cells that were antigen specific as well as the percentage of CD8+ central memory 
cells was significantly higher in both the 45 min and 90 min exercise groups compared to 
no exercise group. This could be due to the downstream activation of these CD8+ T cells 
by increased IFNα production.  
We also saw an increase in MFI of IFN-γ and granzyme B in CD8+ cells in the 45 
and 90 min exercise groups compared to the non-exercise group. The exact mechanism 
for this was not determined in this study but could also be related to increases in IFNα 
production or other exercise mediated pathways. 
CD4 T cell populations were also analyzed by flow cytometry. A nearly opposite 
effect was seen in the CD4 cell populations compared to the CD8 cell populations. Total 
CD4 counts, antigen specific CD4+ cell counts and central memory CD4+ cell counts 
were all significantly less in the 90 min exercise group. There were higher percentages of 
all categories of CD4+ T cells in the 90 min exercise group compared to no exercise. It is 
possible that the increased percentage of cells that were antigen experienced was a strong 
enough response that increasing total numbers of CD4+ cells was not necessary.  
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In summary, although further experiments are necessary to clarify the exact 
mechanism, it appears that 90 minutes of moderate exercise following immunization 
increases antigen-specific IgG and IgG2a, with a trend toward increased IgG1. With 
respect to T cell response, both 45 minutes and 90 minutes of exercise resulted in 
increased numbers of influenza-induced CD8+ T cell, as well as IFN-γ and granzyme B 
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Figure 1. Effects of different durations of exercise immediately post vaccination 
on anti influenza IgG, IgG1 and IgG2a antibody production. 1a,c) IgG and IgG2a anti 
influenza antibody production was significantly higher (p< .05) in the 90min exercise 
mice at 4 weeks post vaccination compared to no exercise mice. There was also a trend 
(p< .1) that antibody in the 90 min exercise group was greater than in the 45 min or 
180min exercise groups.  1b) IgG1 anti influenza antibody production was significantly 
higher (p< .05) in the 90 min exercise mice at 4 weeks post vaccination compared to the 
180min exercise mice. There was also a trend (p< .1) that antibody in the 90 min exercise 
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Figure 2. Effects of differing durations of exercise immediately following 
influenza vaccination on CD8+ T cell populations and products at 4 weeks post 
vaccination. 2a) Total numbers of CD8+ cells (CD8+), antigen specific CD8+ cells 
(CD8+/CD11a+), central memory CD8+ cells (CD8+/CD44+/CD62lo) and naïve CD8+ cells 
(CD8+/CD44-) were significantly higher at 4 weeks post vaccination in both 45min and 
90min exercise compared to no exercise. 2b) Percentage of total CD8+ cells that were 
antigen specific and percentage of central memory cells were significantly higher (p< 
.05) in both the 45min and 90min exercise groups compared to the no exercise group. 
Percentage of naïve CD8+ cells in the 45 and 90 min exercise groups were significantly 
less then the non-exercise group. 2c) MFI of IFN-γ was significantly higher (p< .05) in 
the 45 min and 90 min exercise groups compared to the uninfected as well as non 
exercise groups. There was also a significantly higher MFI for all vaccine groups 
compared to the unvaccinated group (p< .05). MFI of granzyme B in the 45 min and 90 
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Figure 3. Effects of differing durations of exercise immediately following 
influenza vaccination on CD4+ T cell populations at 4 weeks post vaccination. 3a) Total 
numbers of CD4 cells, antigen specific CD4+ cells and central memory CD4+ cells were 
significantly lower at 4 weeks post vaccination in the 90 min exercise group compared to 
45 min exercise. There was also a significant difference in total CD4+ cells and naïve 
CD4+ cells between 90min exercise group and no exercise (p< .05). 3b) The percentage 
of total CD4+ cells that were antigen specific was significantly higher (p< .05) in the 45 
min exercise group compared to no exercise. There was also a trend of a greater 
percentage of antigen specific CD4+ cells from the 90 min exercise group compared to no 
exercise. The percentage of central memory CD4+ cells was no different among any of 
the groups. There was a significantly greater percentage (p< .05) of naïve CD4+ in the 
non-exercise group compared to 90min exercise group.  
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CHAPTER V 
SUMMARY AND CONCLUSIONS FOR THE DISSERTATION 
 
In the introduction to this dissertation the purpose of the research contained within 
the dissertation was laid out as follows: A) to better understand the mechanisms by which 
the duration and intensity of exercise affect the immune system, particularly in response 
to viral challenge, B) determine if exercise can be utilized as a potential vaccine adjuvant 
and C) by what mechanisms exercise produces adjuvant like characteristics.   
Chapter II looked to address the first aim of the dissertation, to better understand 
the mechanisms by which the duration and intensity of exercise affect the immune 
system. Epidemiological evidence shows an increase in URTI following exhaustive 
exercise; research also shows the benefits of moderate intensity exercise. The exact 
mechanisms behind this change in responses with varying amounts of exercise are still 
not entirely understood. One mechanism we proposed was production of IFNα by pDCs. 
Considering the fact that IFNα is one of the body’s first defenses against viral infection, 
any changes in IFNα production due to exercise may prove important in viral defense. 
Recent studies have shown that prolonged exercise, like a marathon or long duration 
triathlon, alters the body’s production of dendritic cell populations, specifically pDCs 86. 
Other studies have shown that shorter more intense bouts of exercise may increase the 
numbers of circulating pDCs immediately after exercise 124.  
Although this particular study of ours did not measure total pDC quantities, we 
were able to measure IFNα production by pDCs. Our initial findings in Chapter II, 
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showed a temporary increase in IFNα production by pDCs after 90min of moderate 
exercise. The temporary exercise-induced increase in pDC production of IFNα after 
90min of exercise may be one mechanism by which exercise improves resistance to 
influenza infection.  This effect is short-term, but may be biologically significant based 
on other findings from our lab in which we observed reduced virus in lungs of mice 
infected 15 minutes after completing exercise 59.  
While 90min of exercise was able to elicit a significant increase in IFNα 
production by pDC, we also found a significant decrease in IFNα production by pDC after 
3hr of moderate intensity exercise. We found this suppression to be the most severe in 
individuals with the greatest levels of fatigue during exercise, the highest levels of 
perceived exertion during exercise and the highest scores on the Beck depression survey. 
This could indicate that the suppression of pDC IFNα production results from a 
combination of physiological and psychological factors.  It is possible that the perception 
of fatigue contributes to immune-suppression in addition to metabolic/energy related 
fatigue.  
To measure more specific physiological factors, pDCs were stimulated with 
catecholamines and cortisol, at the same levels that might occur by 90min of moderate 
exercise. The significant increase in IFNα production in the catecholamine-stimulated 
samples may indicate a possible mechanism by which IFNα production is increased 
during 90min of exercise. This positive effect of epinephrine and norepinephrine may 
outweigh the depressive effects we saw with cortisol stimulation.  
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 While these results are not conclusive as to an exact mechanism that controls 
immune responses during exercise, they may help to understand the changes at least in 
part. Further research is necessary to discover precisely what pathways being affected by 
exercise are causing changes in immune function.  
 After we determined the results from Chapter II, we decided to use this 
knowledge to further investigate the role of exercise on vaccine response. In Chapter III, 
we addressed the second question of this dissertation and to see if 90min of exercise 
could be used as a type of vaccine adjuvant.  
The results from Chapter III showed a significant improvement in antibody 
response to vaccination in subjects who exercised for 90min post vaccination.  These 
positive effects of 90min of exercise immediately following vaccine were seen over 
multiple years and in response to both a novel influenza vaccine as well as the more 
common seasonal influenza vaccine. While the exact mechanisms by which this increase 
occurred are unclear, it may be due in part to the increased IFNα production by pDCs that 
we observed with the same type of exercise.  Despite the increases that were seen from 
90min of exercise, the same benefit was not seen when subjects exercised for only 45min. 
Although this has not been studied in our lab, it is possible that there is not the same 
increase in IFNα after only 45min as was seen after 90min and thus the benefits from 
increased IFNα were not seen.  
Chapter III also added further evidence to the idea that psychological state at the 
time of vaccination may play a role in the subsequent immune response. We saw a 
negative correlation between antibody response and subjects’ responses on the Perceived 
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Stress Scale. This indicates that those subjects who had the greatest degree of perceived 
stress at the time of vaccination had the smallest antibody response to the vaccine. 
Similar outcomes were seen in Experiment B in regards to the negative portion of the 
PANAS.  
In an attempt to further understand some of the mechanisms of how exercise can 
serve as a vaccine adjuvant, we carried out the research in Chapter IV. The results from 
this chapter confirmed the findings of Chapter III and added some new insights. In this 
study, mice were used as a model and different durations of exercise following vaccine 
were used. Mice who exercised 90min post vaccination showed an increased antibody 
titer compared to non-exercising mice and a significant increase in the IgG1 subtype 
compared to the 3hr exercise group. The results of this study further indicate that exercise 
may have “adjuvant-like” effects with respect to influenza vaccination in mice, similar to 
a previous finding in humans. It is possible that the increase in antibody titer due to 
exercise may be related to an increased IFNα production by pDC’s that we observed with 
the same type of exercise in humans.  It could also be related to increases in blood flow 
and capillary permeability caused by exercise altering circulation in such a way that 
greater amounts of antigen reach the draining lymph nodes, although the mechanisms of 
vaccine movement were not measured in this study.  
There is a possibility that IFNα-induced activation of cellular signaling pathways 
may occur during and after the exercise period, resulting in downstream activation of 
antigen presenting cells, B cells and/or CD8+ T cells.  It has been shown that IFNα 
promotes antibody class switching and prolongs CD8+ effector survival. However, further 
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studies are needed to clarify whether IFNα is the primary mechanism mediating this 
effect during exercise. With respect to T cell response, both 45 minutes and 90 minutes of 
exercise resulted in increased numbers of influenza-induced CD8+ T cell, as well as IFNγ 
and granzyme B production by CD8+ T cells. Also, it will be important to identify the 
cellular pathways affected by exercise that result in altered IFNα production, and 
determine how exercise alters these pathways.  Finally, the role of exercise should be 
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Figures for Summary and conclusions 
Fig 1 
 
Figure 1 is a representation of the potential mechanisms presented in this dissertation. 
Those factors which have a positive impact on pDC production of IFNα are indicated 
using a + sign, while those factors which inhibit production of IFNα by pDC are 
indicated by the – sign. The positive increases in IFNα have the subsequent effects shown 
at the bottom of the figure.  
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